{"content":"<li class=\"n-box-item date-title\" data-end=\"1552363199\" data-start=\"1552276800\" data-txt=\"Monday, December 23, 2019\">Monday, March 11, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3441707\" data-ts=\"1552342395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATUS\" target=\"_blank\">ATUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441707-altice-usaminus-2_3-on-report-of-13_5m-share-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altice USA -2.3% on report of 13.5M-share secondary</a></h4><ul>   <li>Altice USA (NYSE:<a href='https://seekingalpha.com/symbol/ATUS' title='Altice USA, Inc.'>ATUS</a>) is <font color=\"red\">down 2.3%</font> postmarket on reports it's shopping a 13.5M-share block for sale, for selling stockholders.</li>    <li>Those shares are expected to come at $21.35-$21.50 each, Bloomberg hears, vs. today's close of $21.80.</li>    <li>Some eight holders own at least that many shares: Next Alt Sarl, BC Partners Holdings, Canada Pension Plan, Goldman Sachs, Vanguard, Dodge &amp; Cox, Capital Group Cos. and Citadel.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441707\" data-linked=\"Altice USA -2.3% on report of 13.5M-share secondary\" data-tweet=\"$ATUS - Altice USA -2.3% on report of 13.5M-share secondary https://seekingalpha.com/news/3441707-altice-usaminus-2_3-on-report-of-13_5m-share-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3441707-altice-usaminus-2_3-on-report-of-13_5m-share-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441694\" data-ts=\"1552340038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441694-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/NM' title='Navios Maritime Holdings Inc.'>NM</a> <font color=\"green\">+22.9%</font>. <a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a> <font color=\"green\">+19.1%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil and Gas, Inc.'>NOG</a> <font color=\"green\">+4.5%</font>. <a href='https://seekingalpha.com/symbol/HLIX' title='Helix TCS, Inc.'>OTCQB:HLIX</a> <font color=\"green\">+2.8%</font>. <a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color=\"green\">+2.4%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a> <font color=\"red\">-23.9%</font>. <a href='https://seekingalpha.com/symbol/ADT' title='ADT Inc.'>ADT</a> <font color=\"red\">-8.0%</font>. <a href='https://seekingalpha.com/symbol/PETQ' title='PetIQ, Inc.'>PETQ</a> <font color=\"red\">-4.3%</font>. <a href='https://seekingalpha.com/symbol/FWONA' title='Formula One Group'>FWONA</a> <font color=\"red\">-4.4%</font>. <a href='https://seekingalpha.com/symbol/EPRT' title='Essential Properties Realty Trust, Inc.'>EPRT</a> <font color=\"red\">-3.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441694\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$NM $SFIX $NOG - After Hours Gainers / Losers https://seekingalpha.com/news/3441694-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441694-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441673\" data-ts=\"1552337576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVD\" target=\"_blank\">AVD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441673-american-vanguardplus-3-after-solid-q4-beat-upside-2019-revenue-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Vanguard +3% after solid Q4 beat, upside 2019 revenue view</a></h4><ul><li>American Vanguard (NYSE:<a href='https://seekingalpha.com/symbol/AVD' title='American Vanguard Corporation'>AVD</a>) <font color=\"green\">+3.1%</font> after-hours after reporting better than expected <a href=\"https://seekingalpha.com/news/3441644-american-vanguard-beats-0_03-misses-revenue\" target=\"_blank\">Q4 earnings</a> and in-line revenues while issuing upside 2019 revenue guidance.</li><li>AVD says Q4 EBITDA totaled $16.6M compared to $14.6M in the year-ago quarter, and was $61.1M for FY 2018 vs. $48.8M in the prior year.</li><li>Despite early season wet weather conditions in the U.S., AVD says it expects FY 2019 global revenues will exceed $500M - ahead of the $486M analyst consensus estimate - gross profit margins should remain in the 38%-40% range and operating expenses are targeted at 31% of  sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441673\" data-linked=\"American Vanguard +3% after solid Q4 beat, upside 2019 revenue view\" data-tweet=\"$AVD - American Vanguard +3% after solid Q4 beat, upside 2019 revenue view https://seekingalpha.com/news/3441673-american-vanguardplus-3-after-solid-q4-beat-upside-2019-revenue-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3441673-american-vanguardplus-3-after-solid-q4-beat-upside-2019-revenue-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441671\" data-ts=\"1552337459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZFGN\" target=\"_blank\">ZFGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441671-zafgen-down-27-after-hours-on-suspension-of-ind-for-zgnminus-1258\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zafgen down 27% after hours on suspension of IND for ZGN-1258</a></h4><ul><li>Thinly traded micro cap Zafgen (NASDAQ:<a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a>) slumps <font color=\"red\">27%</font> after hours in apparent response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1374690/000119312519070841/d659138dex991.htm\" target=\"_blank\">disclosure </a>that it has suspended plans to file an IND in the U.S. seeking signoff to start clinical development of ZGN-1258 for the trial of metabolic disorder called Prader-Willi syndrome.</li><li>The company says it made the decision after \"unexpected findings\" in muscle tissue in four- and six-month rodent toxicity studies, specifically, \"different degrees\" of degeneration and other anomalies in rat muscle tissue in both the dose and vehicle (placebo) arms. The adverse effects were not observed in other animal species in long-term models and, according to Zafgen, other MetAP2 inhibitors or clinical trials.</li><li>Management will update investors at a later time.</li><li>Next quarter, it expects to have an update on type 2 diabetes candidate ZGN-1061, including safety and efficacy data from the second cohort of its Phase 2 study.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441671\" data-linked=\"Zafgen down 27% after hours on suspension of IND for ZGN-1258\" data-tweet=\"$ZFGN - Zafgen down 27% after hours on suspension of IND for ZGN-1258 https://seekingalpha.com/news/3441671-zafgen-down-27-after-hours-on-suspension-of-ind-for-zgnminus-1258?source=tweet\" data-url=\"https://seekingalpha.com/news/3441671-zafgen-down-27-after-hours-on-suspension-of-ind-for-zgnminus-1258\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441670\" data-ts=\"1552337363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNG\" target=\"_blank\">RNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441670-ringcentral-gets-new-buy-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RingCentral gets new Buy rating</a></h4><ul><li>Guggenheim starts RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) at Buy with a PT of $125, implying a 20% upside.</li><li>Last month, RingCentral <a href=\"https://seekingalpha.com/news/3431866-ringcentral-plus-4_9-percent-strong-q4-revenues-upbeat-guidance\" target=\"_blank\">reported</a> strong Q4 revenues with an upside guidance.</li><li>RNG shares are <font color=\"green\">up 0.4%</font> after hours to $105.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441670\" data-linked=\"RingCentral gets new Buy rating\" data-tweet=\"$RNG - RingCentral gets new Buy rating https://seekingalpha.com/news/3441670-ringcentral-gets-new-buy-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3441670-ringcentral-gets-new-buy-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441652\" data-ts=\"1552336102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRNA\" target=\"_blank\">DRNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441652-dicerna-announces-top-2019-milestones-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dicerna announces top 2019 milestones; shares down 2% after hours</a></h4><ul><li>Dicerna Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a>) <a href=\"https://seekingalpha.com/pr/17440201-dicerna-reports-fourth-quarter-year-ended-december-31-2018-financial-results-provides\" target=\"_blank\">announces </a>key events for 2019:</li><li>Initiate long-term, multi-dose, open-label extension study of lead candidate DCR-PHXC in primary hyperoxaluria &#40;PH&#41; in Q2. Additional studies are planned, including PH type 3 patients and a single-dose trial in adults with end-stage renal disease.</li><li>Dosing to commence in Phase 1 study of DCR-HBVS in HBV patients in Q2. Proof-of-concept data should be available in Q4.</li><li>Application to start clinical trials in Europe for undisclosed rare disease program on tap for Q2.</li><li>Shares are down <font color=\"red\">2%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441652\" data-linked=\"Dicerna announces top 2019 milestones; shares down 2% after hours\" data-tweet=\"$DRNA - Dicerna announces top 2019 milestones; shares down 2% after hours https://seekingalpha.com/news/3441652-dicerna-announces-top-2019-milestones-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3441652-dicerna-announces-top-2019-milestones-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441644\" data-ts=\"1552335905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVD\" target=\"_blank\">AVD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441644-american-vanguard-beats-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Vanguard beats by $0.03, misses on revenue</a></h4><ul><li>American Vanguard (NYSE:<a href='https://seekingalpha.com/symbol/AVD' title='American Vanguard Corporation'>AVD</a>): Q4 GAAP EPS of $0.25 <span style=\"color:green\">beats by $0.03</span>.</li><li>Revenue of $131M (+12.9% Y/Y) <font color=\"red\">misses by $0.7M</font>.</li><li>Shares <font color=\"green\">+3.1%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17440205-american-vanguard-reports-fourth-quarter-and-full-year-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3441644\" data-linked=\"American Vanguard beats by $0.03, misses on revenue\" data-tweet=\"$AVD - American Vanguard beats by $0.03, misses on revenue https://seekingalpha.com/news/3441644-american-vanguard-beats-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3441644-american-vanguard-beats-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441643\" data-ts=\"1552335884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADT\" target=\"_blank\">ADT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441643-adt-lower-on-light-ebitda-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ADT lower on light EBITDA guidance</a></h4><ul><li>ADT (NYSE:<a href='https://seekingalpha.com/symbol/ADT' title='ADT Inc.'>ADT</a>) is <font color=\"red\">down 5.5%</font> in AH trading after posting mixed guidance.</li><li>The company expects full-year revenue of $4.9B to $5.1B vs. $4.90B consensus and adjusted EBITDA of $2.46B to $2.50B vs. $2.56B anticipated by analysts.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441607-adt-beats-0_01-beats-revenue\" target=\"_blank\">ADT beats by $0.01, beats on revenue</a> (March 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441643\" data-linked=\"ADT lower on light EBITDA guidance\" data-tweet=\"$ADT - ADT lower on light EBITDA guidance https://seekingalpha.com/news/3441643-adt-lower-on-light-ebitda-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3441643-adt-lower-on-light-ebitda-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441632\" data-ts=\"1552335651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASY\" target=\"_blank\">CASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441632-caseys-general-stores-trickles-lower-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Casey&#39;s General Stores trickles lower after earnings</a></h4><ul><li>Casey's General Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/CASY' title='Casey&#39;s General Stores, Inc.'>CASY</a>) reports an average fuel margin of $0.22 during <a href=\"https://seekingalpha.com/pr/17440242-caseys-reports-strong-3rd-quarter\" target=\"_blank\">Q4</a>, while same-store gallons sold were down 3.4%.</li><li>Same-store sales were up 3.4% for the grocery/other merchandise business with total average margin of 31.9%. Market share was picked up in key categories.</li><li>Same-store sales for the prepared food/fountain were up 1.5% with a total average margin of 62.3%.</li><li>Looking ahead, Casey's sees 2019 same-store sales fuel growth of -2.0% to -0.5% vs. a prior forecast of -1.0% to +0.5%. The retailer expects grocery/other merchandise same-store sales of +1.5% to +3.0% and prepared food/fountain same-store sales of +1.5% to +3.5%.</li><li>CASY <font color=\"green\">+0.59%</font> AH.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441632\" data-linked=\"Casey&#39;s General Stores trickles lower after earnings\" data-tweet=\"$CASY - Casey&#39;s General Stores trickles lower after earnings https://seekingalpha.com/news/3441632-caseys-general-stores-trickles-lower-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3441632-caseys-general-stores-trickles-lower-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441628\" data-ts=\"1552335462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COUP\" target=\"_blank\">COUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441628-coupa-softwareplus-3-on-q4-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coupa Software +3% on Q4 beats</a></h4><ul><li>Coupa Software (NASDAQ:<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Incorporated'>COUP</a>) <font color=\"green\">gains 3% </font>after hours on Q4 beats with 39% Y/Y revenue growth. The mixed Q1 guidance has revenue from $73.5M to $74M (consensus: $70.15M) and EPS from -$0.06 to -$0.03 (consensus: -$0.02).</li><li>Mixed FY20 guidance has revenue from $325M to $327M (consensus: $315.13M) and EPS from $0.04 to $0.10 (consensus: $0.23).</li><li>Q4 subscription and professional services revenues beat estimates with a reported $67.5M and $7.4M, respectively.</li><li>Non-GAAP operating margin was 3.2% versus the 0.2% consensus.</li><li>Billings totaled $127.4M compared to the $105.7M estimate.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=2399186-1&amp;h=323486914&amp;u=http%3A%2F%2Finvestors.coupa.com%2F&amp;a=http%3A%2F%2Finvestors.coupa.com\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17440210-coupa-software-reports-fourth-quarter-and-full-year-fiscal-2019-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441603-coupa-software-beats-0_05-beats-revenue\" target=\"_blank\">Coupa Software beats by $0.05, beats on revenue</a> (March 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441628\" data-linked=\"Coupa Software +3% on Q4 beats\" data-tweet=\"$COUP - Coupa Software +3% on Q4 beats https://seekingalpha.com/news/3441628-coupa-softwareplus-3-on-q4-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3441628-coupa-softwareplus-3-on-q4-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441611\" data-ts=\"1552335036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441611-stitch-fixplus-7-after-ebitda-dazzles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stitch Fix+7% after EBITDA dazzles</a></h4><ul><li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) is on watch after the retailer's EBITDA tally for <a href=\"https://seekingalpha.com/pr/17440229-stitch-fix-announces-second-quarter-fiscal-year-2019-financial-results\" target=\"_blank\">FQ2</a> topped even the highest estimate turned in by analysts covering the stock.</li><li>Stitch Fix reports EBITDA came in at $19.2M vs. $18.1M a year ago and $11.3M consensus estimate.</li><li>Active clients rose 18% Y/Y during the quarter and total revenue was up 25%.</li><li>Shares of Stitch Fix <font color=\"green\">+7.07%</font> AH.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441605-stitch-fix-beats-0_07-beats-revenue\" target=\"_blank\">Stitch Fix beats by $0.07, beats on revenue</a> (March 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441611\" data-linked=\"Stitch Fix+7% after EBITDA dazzles\" data-tweet=\"$SFIX - Stitch Fix+7% after EBITDA dazzles https://seekingalpha.com/news/3441611-stitch-fixplus-7-after-ebitda-dazzles?source=tweet\" data-url=\"https://seekingalpha.com/news/3441611-stitch-fixplus-7-after-ebitda-dazzles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441605\" data-ts=\"1552334892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441605-stitch-fix-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stitch Fix beats by $0.07, beats on revenue</a></h4><ul><li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>): Q2 Non-GAAP EPS of $0.12; GAAP EPS of $0.12 <span style=\"color:green\">beats by $0.07</span>.</li><li>Revenue of $370.28M (+25.1% Y/Y) <font color=\"green\">beats by $5.42M</font>.</li><li>Shares <font color=\"green\">+7%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17440229-stitch-fix-announces-second-quarter-fiscal-year-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3441605\" data-linked=\"Stitch Fix beats by $0.07, beats on revenue\" data-tweet=\"$SFIX - Stitch Fix beats by $0.07, beats on revenue https://seekingalpha.com/news/3441605-stitch-fix-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3441605-stitch-fix-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441604\" data-ts=\"1552334877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDRA\" target=\"_blank\">NDRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441604-endra-life-sciences-reports-fy-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endra Life Sciences reports FY results</a></h4><ul><li>Endra Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>): FY GAAP EPS of -$2.17.</li><li>Revenue of $0.06M (-82.9% Y/Y)</li><li>Shares <font color=\"green\">+4.74%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17440196-endra-life-sciences-reports-full-year-2018-financial-and-operational-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3441604\" data-linked=\"Endra Life Sciences reports FY results\" data-tweet=\"$NDRA - Endra Life Sciences reports FY results https://seekingalpha.com/news/3441604-endra-life-sciences-reports-fy-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3441604-endra-life-sciences-reports-fy-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441595\" data-ts=\"1552334365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441595-allergan-adds-to-hoped-for-changes-stoked-rally-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan adds to hoped-for-changes-stoked rally, up 1%</a></h4><ul><li>Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"green\">+1.1%</font>) has rallied over <font color=\"green\">8%</font> since touching $135.88 last Thursday when it announced disappointing results for MDD candidate rapastinel. The modest up move is apparently being driven by hopes that the flop will ratchet up the pressure on Chairman, President &amp; CEO Brent Saunders to shake things up.</li><li>Bernstein's Ronny Gal <a href=\"https://www.barrons.com/articles/boeing-stock-ethiopian-airlines-crash-737-max-8-51552310854\" target=\"_blank\">believes </a>a breakup is one of the fastest ways to unlock value, a move that Allergan management has yet to embrace. Mr. Gal also thinks that a simple announcement about a long-term plan to break the company in two would go a long way to calm investors concerned with potential value destruction from hasty action.</li><li>Mr. Saunders has so far stiff-armed value-boosting ideas and to split the Chairman and CEO roles, saying he just needs a bit more time to execute his strategy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441595\" data-linked=\"Allergan adds to hoped-for-changes-stoked rally, up 1%\" data-tweet=\"$AGN - Allergan adds to hoped-for-changes-stoked rally, up 1% https://seekingalpha.com/news/3441595-allergan-adds-to-hoped-for-changes-stoked-rally-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3441595-allergan-adds-to-hoped-for-changes-stoked-rally-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441592\" data-ts=\"1552333846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441592-petrobras-eyes-another-8_1b-in-operational-cost-cuts-through-2023\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras eyes another $8.1B in operational cost cuts through 2023</a></h4><ul><li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petróleo Brasileiro S.A. - Petrobras'>PBR</a> <font color='green'>+6.4%</font>) powers higher after unveiling <a href=\"https://www.reuters.com/article/us-petrobras-outlook-costs/petrobras-plans-to-cut-8-1-bln-in-operational-costs-through-2023-idUSKBN1QQ02E\" target=\"_blank\">plans to cut $8.1B from its operational costs</a> through 2023, according to a securities filing released on Friday.</li><li>The company claims it can reach the cost goal  mainly through reductions in  expenses with employees, including the launch soon of a voluntary layoff plan, as well as lower expenditures in advertisement and office spaces.</li><li>PBR's new \"resilience plan\" also foresees an expansion of its $26.9B five-year  divestment plan and the release of excess cash for investment.</li><li>PBR also has <a href=\"https://www.argusmedia.com/en/news/1863383-petrobras-to-cut-more-costs-delays-offshore-unit\" target=\"_blank\">delayed the installation</a> of a fifth production platform at  the Buzios pre-salt field by a year to 2022 as part of its deeper  cost-cutting plan.</li><li>The company is maintaining the timeline for the other four platforms  scheduled to come on stream across the pre-salt patch in 2019-21 and  another six in 2022-23; PBR estimates its oil and gas production  will grow at a 5% annual rate through 2023.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441592\" data-linked=\"Petrobras eyes another $8.1B in operational cost cuts through 2023\" data-tweet=\"$PBR - Petrobras eyes another $8.1B in operational cost cuts through 2023 https://seekingalpha.com/news/3441592-petrobras-eyes-another-8_1b-in-operational-cost-cuts-through-2023?source=tweet\" data-url=\"https://seekingalpha.com/news/3441592-petrobras-eyes-another-8_1b-in-operational-cost-cuts-through-2023\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441591\" data-ts=\"1552333437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YTRA\" target=\"_blank\">YTRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441591-yatra-online-confirms-considers-ebix-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yatra Online confirms, considers Ebix offer</a></h4><ul><li>Yatra Online (<a href='https://seekingalpha.com/symbol/YTRA' title='Yatra Online, Inc.'>YTRA</a> <font color='green'>+31.3%</font>) <a href=\"https://seekingalpha.com/pr/17440159-yatra-online-review-proposal-ebix\" target=\"_blank\">confirms</a> receiving an acquisition offer from Ebix (<a href='https://seekingalpha.com/symbol/EBIX' title='Ebix, Inc.'>EBIX</a> <font color='green'>+1.6%</font>) and says its board will \"review and consider the proposal\" to determine the best course of action.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441511-yatra-plus-38-percent-ebix-buyout-offer\" target=\"_blank\">Yatra +38% on Ebix buyout offer</a> (March 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441591\" data-linked=\"Yatra Online confirms, considers Ebix offer\" data-tweet=\"$YTRA $EBIX - Yatra Online confirms, considers Ebix offer https://seekingalpha.com/news/3441591-yatra-online-confirms-considers-ebix-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3441591-yatra-online-confirms-considers-ebix-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441589\" data-ts=\"1552333096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPR\" target=\"_blank\">SPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441589-spirit-aerosystems-boeing-linked-names-tumble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spirit AeroSystems, Boeing-linked names tumble</a></h4><ul><li>Spirit AeroSystems (<a href='https://seekingalpha.com/symbol/SPR' title='Spirit AeroSystems Holdings, Inc.'>SPR</a> <font color='red'>-3.6%</font>), which makes fuselages for the Boeing 737 Max 8, is sharply lower but well off morning lows following the deadly crash (<a href=\"https://seekingalpha.com/news/3441321-ethiopian-airlines-no-survivors-crashed-boeing-737\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/news/3441330-boeing-minus-9-percent-china-suspends-737-max-8-operations\" target=\"_blank\">II</a>, <a href=\"https://seekingalpha.com/news/3441523-boeing-pares-big-losses-shares-now-5_6-percent\" target=\"_blank\">III</a>) of an Ethiopian Airlines flight involving a brand-new 737 MAX 8 aircraft in the second such crash involving the aircraft in recent months.</li><li>SPR identifies itself as \"the largest independent supplier of aerostructures to Boeing,\" manufacturing aerostructures \"for every Boeing commercial aircraft currently in production.\"</li><li>Other key Boeing suppliers and customers also are lower, including Triumph Group (<a href='https://seekingalpha.com/symbol/TGI' title='Triumph Group, Inc.'>TGI</a> <font color='red'>-3.7%</font>), Air Lease (<a href='https://seekingalpha.com/symbol/AL' title='Air Lease Corporation'>AL</a> <font color='red'>-1.6%</font>) and Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color='red'>-0.3%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3441589\" data-linked=\"Spirit AeroSystems, Boeing-linked names tumble\" data-tweet=\"$SPR $TGI $AL - Spirit AeroSystems, Boeing-linked names tumble https://seekingalpha.com/news/3441589-spirit-aerosystems-boeing-linked-names-tumble?source=tweet\" data-url=\"https://seekingalpha.com/news/3441589-spirit-aerosystems-boeing-linked-names-tumble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441587\" data-ts=\"1552332321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGN\" target=\"_blank\">REGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441587-fda-oks-regeneron-and-sanofis-dupixent-for-younger-patients-atopic-dermatitis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Regeneron and Sanofi&#39;s Dupixent for younger patients with atopic dermatitis</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17440171-fda-approves-dupixent-dupilumab-moderate-severe-atopic-dermatitis-adolescents\" target=\"_blank\">approves </a>Regeneron Pharmaceuticals (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color=\"green\">+2.1%</font>) and development partner Sanofi's (<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a> <font color=\"green\">+1.3%</font>) Dupixent (dupilumab) for patients ages 12 - 17 with moderate-to-severe atopic dermatitis (eczema) who have failed to respond adequately to topical therapies.</li><li>The FDA approved the med to treat adults with eczema two years ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441587\" data-linked=\"FDA OKs Regeneron and Sanofi&#39;s Dupixent for younger patients with atopic dermatitis\" data-tweet=\"$REGN $SNY - FDA OKs Regeneron and Sanofi&#39;s Dupixent for younger patients with atopic dermatitis https://seekingalpha.com/news/3441587-fda-oks-regeneron-and-sanofis-dupixent-for-younger-patients-atopic-dermatitis?source=tweet\" data-url=\"https://seekingalpha.com/news/3441587-fda-oks-regeneron-and-sanofis-dupixent-for-younger-patients-atopic-dermatitis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441586\" data-ts=\"1552331651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLUE\" target=\"_blank\">BLUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441586-sickle-cell-players-in-green-after-60-minutes-piece\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sickle cell players in the green after 60 Minutes piece</a></h4><ul><li>Biotechs developing gene therapies for sickle cell disease are seeing a modest uptick in buying after a <a href=\"https://www.cbsnews.com/news/could-gene-therapy-cure-sickle-cell-anemia-60-minutes/\" target=\"_blank\">60 Minutes segment</a> last night on the preliminary success of an unnamed gene therapy. The patient who was the primary focus appeared to have completely responded and she has been pain-free from vaso-occlusive crises since receiving the one-time treatment.</li><li>Selected tickers: bluebird bio (<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color=\"green\">+4.8%</font>), CRISPR Therapeutics (<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a> <font color=\"green\">+3%</font>), Vertex Pharmaceuticals (<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color=\"green\">+1.4%</font>), Editas Medicine (<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine, Inc.'>EDIT</a> <font color=\"green\">+3.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441586\" data-linked=\"Sickle cell players in the green after 60 Minutes piece\" data-tweet=\"$BLUE $CRSP $VRTX - Sickle cell players in the green after 60 Minutes piece https://seekingalpha.com/news/3441586-sickle-cell-players-in-green-after-60-minutes-piece?source=tweet\" data-url=\"https://seekingalpha.com/news/3441586-sickle-cell-players-in-green-after-60-minutes-piece\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441583\" data-ts=\"1552331375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWR\" target=\"_blank\">GWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441583-genesee-wyoming-in-talks-multiple-interested-parties-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genesee &amp; Wyoming in talks with multiple interested parties - Bloomberg</a></h4><ul> <li>Genesee &amp; Wyoming (<a href='https://seekingalpha.com/symbol/GWR' title='Genesee & Wyoming Inc.'>GWR</a> <font color='green'>+7.9%</font>) is in <a href=\"https://www.bloomberg.com/news/articles/2019-03-11/railroad-owner-genesee-wyoming-is-said-to-explore-stake-sale\" target=\"_blank\">talks</a> with  Brookfield Asset Management and other infrastructure-investment firms about a series of strategic options, including selling off a minority position in the company, according to Bloomberg.</li> <li>Sources characterize the talks as being in the early stage.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441578-genesee-and-wyoming-spikes-report-potential-sale-stake\" target=\"_blank\">Genesee &amp; Wyoming spikes off report of potential sale of stake</a> (March 11)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3441583\" data-linked=\"Genesee &amp; Wyoming in talks with multiple interested parties - Bloomberg\" data-tweet=\"$GWR - Genesee &amp; Wyoming in talks with multiple interested parties - Bloomberg https://seekingalpha.com/news/3441583-genesee-wyoming-in-talks-multiple-interested-parties-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3441583-genesee-wyoming-in-talks-multiple-interested-parties-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441582\" data-ts=\"1552330989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441582-technology-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong>DropCar (NASDAQ:<a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a>) <font color=\"green\">+37%</font>. USA Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a>) <font color=\"green\">+17%</font>. China Finance Online (NASDAQ:<a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a>) <font color=\"green\">+16%</font>. Internap Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/INAP' title='Internap Corporation'>INAP</a>) <font color=\"green\">+16%</font>. GTT Communications (NYSE:<a href='https://seekingalpha.com/symbol/GTT' title='GTT Communications, Inc.'>GTT</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>Care.com (NYSE:<a href='https://seekingalpha.com/symbol/CRCM' title='Care.com, Inc.'>CRCM</a>) <font color=\"red\">-13%</font>. Eventbrite (NYSE:<a href='https://seekingalpha.com/symbol/EB' title='Eventbrite, Inc.'>EB</a>) <font color=\"red\">-6%</font>. CYREN (NASDAQ:<a href='https://seekingalpha.com/symbol/CYRN' title='CYREN Ltd.'>CYRN</a>) <font color=\"red\">-6%</font>. Aurora Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/JG' title='Aurora Mobile Limited'>JG</a>) <font color=\"red\">-5%</font>. CBAK Energy Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/CBAT' title='CBAK Energy Technology, Inc.'>CBAT</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441582\" data-linked=\"Technology - Top 5 Gainers / Losers\" data-tweet=\"$DCAR $USAT $JRJC - Technology - Top 5 Gainers / Losers https://seekingalpha.com/news/3441582-technology-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441582-technology-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441581\" data-ts=\"1552330685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441581-rokuplus-3_6-on-nearing-airplay-2-support-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku +3.6% on nearing AirPlay 2 support - report</a></h4><ul><li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a>) <font color=\"green\">gains 3.6%</font> on a <a href=\"https://www.macrumors.com/2019/03/11/roku-airplay-2/\" target=\"_blank\">Mac Rumors</a> report that negotiations are nearly finalized to support Apple's (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+3.3%</font>) AirPlay 2.</li><li>Sources say the AirPlay 2 integration will come through a Roku OS software update. Roku-enabled smart televisions will also get AirPlay 2 support.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441581\" data-linked=\"Roku +3.6% on nearing AirPlay 2 support - report\" data-tweet=\"$ROKU $ROKU $AAPL - Roku +3.6% on nearing AirPlay 2 support - report https://seekingalpha.com/news/3441581-rokuplus-3_6-on-nearing-airplay-2-support-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3441581-rokuplus-3_6-on-nearing-airplay-2-support-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441580\" data-ts=\"1552330257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPB\" target=\"_blank\">TPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441580-turning-point-brands-rallies-to-new-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turning Point Brands rallies to new high</a></h4><ul> <li>Turning Point Brands (NYSE:<a href='https://seekingalpha.com/symbol/TPB' title='Turning Point Brands, Inc.'>TPB</a>) rallies <font color=\"green\">7.50%</font> after last week's earnings report continues to be assessed favorably by investors.</li> <li>Shares of TPB hit a post-IPO high of $47.44 earlier in the session. The tobacco products company priced its IPO at $10 per share back in 2016.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3439762-turning-point-brands-eps-line-beats-revenue\" target=\"_blank\">Turning Point Brands EPS in-line, beats on revenue</a> (March 5)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3441580\" data-linked=\"Turning Point Brands rallies to new high\" data-tweet=\"$TPB - Turning Point Brands rallies to new high https://seekingalpha.com/news/3441580-turning-point-brands-rallies-to-new-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3441580-turning-point-brands-rallies-to-new-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441579\" data-ts=\"1552329917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENB\" target=\"_blank\">ENB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441579-pipeline-delay-spooks-traders-in-long-term-canadian-crude-market-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pipeline delay spooks traders in long-term Canadian crude market - Reuters</a></h4><ul><li>North American energy traders are <a href=\"https://www.reuters.com/article/us-canada-oil-pipeline/enbridge-pipeline-delay-spooks-traders-in-long-term-canada-crude-market-idUSKBN1QR0IE\" target=\"_blank\">reluctant to take up long-term  positions on Canadian crude price moves</a>, preferring to stick to spot  deals, as the <a href=\"https://seekingalpha.com/news/3439865-enbridge-line-3-delay-seen-causing-crude-rail-alberta-cuts-extended\" target=\"_blank\">unexpected one-year delay</a> to Enbridge's (<a href='https://seekingalpha.com/symbol/ENB' title='Enbridge Inc.'>ENB</a> <font color='green'>+1.9%</font>) Line 3 pipeline project adds to uncertainty around government intervention in the market.</li><li>The Line 3 delay has heightened concerns the government may impose cuts for longer than its current target of year-end 2019.</li><li>\"Everything we heard from the government was that they were 100%  relying on Line 3 coming into service at the end of 2019,\" says Tim  Pickering of Auspice Capital Advisors.</li><li>Canada is the world\u2019s fourth biggest oil producer and the heavy crude it produces is in high demand in the U.S., but sources at producers and refiners on both sides of the border say it  has become more difficult to make a compelling case to buy  Canadian oil contracts for later in the year because of the uncertainty  related to what the government might do, according to the report.</li><li>Hedge funds, who typically trade financial contracts rather than  physical barrels, also are reluctant to get involved in Canada now,  Pickering says, leading to a thinner market with fewer participants.</li><li>Other potential relevant tickers include <a href='https://seekingalpha.com/symbol/CNQ' title='Canadian Natural Resources Limited'>CNQ</a>, <a href='https://seekingalpha.com/symbol/SU' title='Suncor Energy Inc.'>SU</a>, <a href='https://seekingalpha.com/symbol/IMO' title='Imperial Oil Limited'>IMO</a>, <a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy Inc.'>CVE</a>, <a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a>, <a href='https://seekingalpha.com/symbol/TRP' title='TransCanada Corporation'>TRP</a>, <a href='https://seekingalpha.com/symbol/CPG' title='Crescent Point Energy Corp.'>CPG</a>, <a href='https://seekingalpha.com/symbol/BTE' title='Baytex Energy Corp.'>BTE</a>, <a href='https://seekingalpha.com/symbol/ERF' title='Enerplus Corporation'>ERF</a>, <a href='https://seekingalpha.com/symbol/HUSKF' title='Husky Energy Inc.'>OTCPK:HUSKF</a>, <a href='https://seekingalpha.com/symbol/PGHEF' title='Pengrowth Energy Corporation'>OTCQX:PGHEF</a>, <a href='https://seekingalpha.com/symbol/MEGEF' title='MEG Energy Corp.'>OTCPK:MEGEF</a>, <a href='https://seekingalpha.com/symbol/ATHOF' title='Athabasca Oil Corporation'>OTCPK:ATHOF</a>, <a href='https://seekingalpha.com/symbol/SPGYF' title='Whitecap Resources Inc.'>OTCPK:SPGYF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3441579\" data-linked=\"Pipeline delay spooks traders in long-term Canadian crude market - Reuters\" data-tweet=\"$ENB $CNQ $SU - Pipeline delay spooks traders in long-term Canadian crude market - Reuters https://seekingalpha.com/news/3441579-pipeline-delay-spooks-traders-in-long-term-canadian-crude-market-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3441579-pipeline-delay-spooks-traders-in-long-term-canadian-crude-market-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441578\" data-ts=\"1552329623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441578-genesee-wyoming-spikes-off-report-of-potential-sale-of-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genesee &amp; Wyoming spikes off report of potential sale of stake</a></h4><ul> <li>Genesee &amp; Wyoming (<a href='https://seekingalpha.com/symbol/GWR' title='Genesee & Wyoming Inc.'>GWR</a> <font color='green'>+8.5%</font>) rallies off a report that the company is exploring options, including the sale of a minority stake.</li> <li>Kansas City Southern (<a href='https://seekingalpha.com/symbol/KSU' title='Kansas City Southern'>KSU</a> <font color='green'>+2.2%</font>), Norfolk Southern (<a href='https://seekingalpha.com/symbol/NSC' title='Norfolk Southern Corporation'>NSC</a> <font color='green'>+2%</font>), CSC (<a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a> <font color='green'>+1.3%</font>) and Union Pacific (<a href='https://seekingalpha.com/symbol/UNP' title='Union Pacific Corporation'>UNP</a> <font color='green'>+1%</font>) are also higher on the day amid the spotlight on the sector.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3441578\" data-linked=\"Genesee &amp; Wyoming spikes off report of potential sale of stake\" data-tweet=\"$GWR $KSU $NSC - Genesee &amp; Wyoming spikes off report of potential sale of stake https://seekingalpha.com/news/3441578-genesee-wyoming-spikes-off-report-of-potential-sale-of-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3441578-genesee-wyoming-spikes-off-report-of-potential-sale-of-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441575\" data-ts=\"1552329094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNG\" target=\"_blank\">LNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441575-cheniere-lng-exports-to-china-double-companys-size-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheniere LNG exports to China could double company&#39;s size, CEO says</a></h4><ul><li>Cheniere Energy (<a href='https://seekingalpha.com/symbol/LNG' title='Cheniere Energy, Inc.'>LNG</a> <font color='green'>+2.3%</font>) <a href=\"https://www.cnbc.com/2019/03/11/cheniere-lng-exports-to-china-can-double-its-size-if-trade-war-ends.html\" target=\"_blank\">could ultimately double its size</a> through liquefied natural gas exports to China but current trade tensions between the U.S. and China must be resolved, CEO Jack Fusco tells CNBC.</li><li>\"At the lower levels, we don't see much change. There's two willing  counterparties trying to talk about terms... At the upper level,  though, there's some tension, and I think until the tension gets  smoothed out... it's going to be rocky and it's going to be lumpy,\" Fusco says.</li><li>The CEO says Cheniere already has sent more than 60 tankers with LNG to China from its Sabine Pass  terminal, the first LNG export terminal in the lower 48 U.S. states.</li><li>Separately, the Federal Energy Regulatory Commission gave Cheniere <a href=\"https://www.chron.com/business/energy/article/Feds-approve-introducing-feed-gas-into-Train-2-at-13679131.php\" target=\"_blank\">permission to start introducing feed gas</a> into the Train 2 production unit at its Corpus Christi LNG export terminal.</li><li>FERC's order comes less than two weeks after FERC  officials gave Cheniere permission to begin commercial operations for  Train 1 at Corpus Christi LNG.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441575\" data-linked=\"Cheniere LNG exports to China could double company&#39;s size, CEO says\" data-tweet=\"$LNG - Cheniere LNG exports to China could double company&#39;s size, CEO says https://seekingalpha.com/news/3441575-cheniere-lng-exports-to-china-double-companys-size-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3441575-cheniere-lng-exports-to-china-double-companys-size-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441570\" data-ts=\"1552327971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTRH\" target=\"_blank\">WTRH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441570-waitrplus-16_7-on-hedgeye-best-idea\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Waitr +16.7% on Hedgeye Best Idea</a></h4><ul><li>Waitr (NASDAQ:<a href='https://seekingalpha.com/symbol/WTRH' title='Waitr Holdings Inc.'>WTRH</a>) <font color=\"green\">gains 16.7%</font> after Hedgeye calls it a Best Idea Long with a potential 50% upside.</li><li>Source: Bloomberg headlines.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441570\" data-linked=\"Waitr +16.7% on Hedgeye Best Idea\" data-tweet=\"$WTRH - Waitr +16.7% on Hedgeye Best Idea https://seekingalpha.com/news/3441570-waitrplus-16_7-on-hedgeye-best-idea?source=tweet\" data-url=\"https://seekingalpha.com/news/3441570-waitrplus-16_7-on-hedgeye-best-idea\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441569\" data-ts=\"1552327898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441569-transoceanplus-5-after-winning-petrobras-contracts-for-ex-ocean-rig-drillships\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean +5% after winning Petrobras contracts for ex-Ocean Rig drillships</a></h4><ul><li>Transocean (<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='green'>+5.6%</font>) powers higher after announcing overnight that Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petróleo Brasileiro S.A. - Petrobras'>PBR</a> <font color='green'>+6%</font>) had <a href=\"https://seekingalpha.com/pr/17439134-transocean-ltd-announces-contract-award-ocean-rig-corcovado-ocean-rig-mykonos\" target=\"_blank\">awarded contracts</a> for the <em>Ocean Rig Corcovado</em> and <em>Ocean Rig Mykonos</em>, two ultra-deepwater drillships acquired in its December purchase of Ocean Rig UDW.</li><li>The estimated firm contract backlog, excluding mobilization, is  $123M for the <em>Corcovado</em> and $118M for the <em>Mykonos</em>, resulting in respective <a href=\"https://www.offshoreenergytoday.com/transocean-bags-petrobras-contracts-for-ex-ocean-rig-drillships/\" target=\"_blank\">dayrates of $195K and $214K</a>.</li><li>The rigs are expected to begin work in Brazil this November and the contracts include priced options for 680 days and 815 days, respectively.</li><li><a href=\"https://seekingalpha.com/news/3441499-transocean-offshore-oil-drilling-stocks-bargains-barrons\" target=\"_blank\">Also</a>: Transocean, offshore oil drilling stocks are bargains - Barron's (Mar. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441569\" data-linked=\"Transocean +5% after winning Petrobras contracts for ex-Ocean Rig drillships\" data-tweet=\"$RIG $PBR - Transocean +5% after winning Petrobras contracts for ex-Ocean Rig drillships https://seekingalpha.com/news/3441569-transoceanplus-5-after-winning-petrobras-contracts-for-ex-ocean-rig-drillships?source=tweet\" data-url=\"https://seekingalpha.com/news/3441569-transoceanplus-5-after-winning-petrobras-contracts-for-ex-ocean-rig-drillships\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441566\" data-ts=\"1552327113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441566-phunware-and-legacy-reserves-among-energy-materials-gainers-pedevco-and-san-juan-basin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phunware and Legacy Reserves among Energy/Materials gainers; PEDEVCO and San Juan Basin Royalty Trust among losers</a></h4><ul><li><b>Gainers: </b>Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware Inc.'>PHUN</a>) <font color=\"green\">+15%</font>. Legacy Reserves (NASDAQ:<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc.'>LGCY</a>) <font color=\"green\">+11%</font>. Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"green\">+10%</font>. ION Geophysical (NYSE:<a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a>) <font color=\"green\">+9%</font>. Altus Midstream (NASDAQ:<a href='https://seekingalpha.com/symbol/ALTM' title='Altus Midstream Company'>ALTM</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"red\">-12%</font>. San Juan Basin Royalty Trust (NYSE:<a href='https://seekingalpha.com/symbol/SJT' title='San Juan Basin Royalty Trust'>SJT</a>) <font color=\"red\">-9%</font>. Pacific Ethanol (NASDAQ:<a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a>) <font color=\"red\">-8%</font>. SenesTech (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech, Inc.'>SNES</a>) <font color=\"red\">-8%</font>. Sanchez Midstream Partners (NYSEMKT:<a href='https://seekingalpha.com/symbol/SNMP' title='Sanchez Midstream Partners LP'>SNMP</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441566\" data-linked=\"Phunware and Legacy Reserves among Energy/Materials gainers; PEDEVCO and San Juan Basin Royalty Trust among losers\" data-tweet=\"$LGCY $BRS $IO - Phunware and Legacy Reserves among Energy/Materials gainers; PEDEVCO and San Juan Basin Royalty Trust among losers https://seekingalpha.com/news/3441566-phunware-and-legacy-reserves-among-energy-materials-gainers-pedevco-and-san-juan-basin?source=tweet\" data-url=\"https://seekingalpha.com/news/3441566-phunware-and-legacy-reserves-among-energy-materials-gainers-pedevco-and-san-juan-basin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441558\" data-ts=\"1552325677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORGO\" target=\"_blank\">ORGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441558-organogenesis-up-35-ahead-of-q4-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Organogenesis up 35% ahead of Q4 report</a></h4><ul><li>Thinly traded small cap <a href=\"https://organogenesis.com/products/index.html\" target=\"_blank\">Organogenesis Holdings</a> (<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc.'>ORGO</a> <font color=\"green\">+35.1%</font>) is up on an 11x surge in volume, albeit on turnover of only 472K shares, on no apparent news.</li><li>On Monday, March 18, it is scheduled to release Q4 and 2018 results. On February 12, it <a href=\"https://www.sec.gov/Archives/edgar/data/1661181/000119312519034755/d670529d8k.htm\" target=\"_blank\">reported </a>that it expects Q4 revenues of $62.1M - 63.1M and 2018 revenues of $192M - 193M. 2018 assumptions include net revenue from Advanced Wound Care of $163.1M - 164M (down 8 - 9% yoy), $28.9M - 29M (up 47 - 48%) in net revenue from Surgical &amp; Sports Medicine and $68.1M - 69.1M from PuraPly (down 37 - 38%).</li><li><strong>2019 guidance</strong>: <a href=\"https://www.sec.gov/Archives/edgar/data/1661181/000119312519034755/d670529d8k.htm\" target=\"_blank\">Revenues</a>: $248M - 259M (up 29 - 35%); Advanced Wound Care: 219M - 229M (up 34 - 40%); Surgical &amp; Sports Medicine: $29.5M - 31M (up 2 - 7%); PuraPly: $96M - 103M (up 40 - 50%).</li><li>Next Wednesday, March 20, management will deliver a <a href=\"https://seekingalpha.com/pr/17439269-organogenesis-holdings-inc-present-oppenheimer-s-29th-annual-healthcare-conference\" target=\"_blank\">corporate overview</a> at Oppenheimer's Annual Healthcare Conference in New York City.</li><li>Last month, the company filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1661181/000119312519040965/d703920d424b3.htm\" target=\"_blank\">prospectus </a>for the resale of up to ~31.4M shares of common stock by current investors.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441558\" data-linked=\"Organogenesis up 35% ahead of Q4 report\" data-tweet=\"$ORGO - Organogenesis up 35% ahead of Q4 report https://seekingalpha.com/news/3441558-organogenesis-up-35-ahead-of-q4-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3441558-organogenesis-up-35-ahead-of-q4-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441717\" data-ts=\"1552324328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECA\" target=\"_blank\">ECA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441717-encanaplus-3-s-and-p-hikes-credit-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Encana +3% as S&amp;P hikes credit rating</a></h4><ul><li>Encana (<a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a> <font color='green'>+2.8%</font>) is higher after Standard &amp; Poor's <a href=\"https://www.ademcetinkaya.com/2019/03/encana-corp-upgraded-to-bbb-from-bbb-on.html\" target=\"_blank\">raises its credit rating</a> to BBB from BBB-, expecting the company will continue to show its strong profitability and meet its future production targets as it integrates assets from the recent acquisition of Newfield Exploration.</li><li>S&amp;P also removes the company from Credit Watch, where it was placed upon the merger announcement.</li><li>S&amp;P believes the reservoir quality and geology of the assets acquired from Newfield are analogous with ECA's existing assets, which limits possible execution risks associated with operating the newly acquired U.S. producing properties.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441717\" data-linked=\"Encana +3% as S&amp;P hikes credit rating\" data-tweet=\"$ECA - Encana +3% as S&amp;P hikes credit rating https://seekingalpha.com/news/3441717-encanaplus-3-s-and-p-hikes-credit-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3441717-encanaplus-3-s-and-p-hikes-credit-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441549\" data-ts=\"1552324105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VOD\" target=\"_blank\">VOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441549-vodafone-italia-preps-many-1130-job-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vodafone Italia preps as many as 1,130 job cuts</a></h4><ul>   <li>Vodafone Italia (<a href=\"http://seekingalpha.com/symbol/VOD\" target=\"_blank\">VOD</a> <font color=\"green\">+1.8%</font>) has presented a business plan that includes a <a href=\"https://www.telecompaper.com/news/vodafone-italia-may-axe-up-to-1130-jobs--1284165\" target=\"_blank\">potential 1,130 job cuts</a>.</li>    <li>That's about 15% of Vodafone's Italian workforce.</li>    <li>The company has started negotiating with trade unions over the moves and says layoffs would involve workers across all company functions.</li>    <li>Vodafone says it's faced a \"drastic fall in prices\" due to competitive pressure, especially in mobile.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441549\" data-linked=\"Vodafone Italia preps as many as 1,130 job cuts\" data-tweet=\"$VOD - Vodafone Italia preps as many as 1,130 job cuts https://seekingalpha.com/news/3441549-vodafone-italia-preps-many-1130-job-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3441549-vodafone-italia-preps-many-1130-job-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441546\" data-ts=\"1552323776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441546-microcaps-dominate-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate midday movers</a></h4><ul><li><strong>Gainers: </strong>Globus Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Limited'>GLBS</a>) <font color=\"green\">+84%</font>. Organogenesis Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc.'>ORGO</a>) <font color=\"green\">+61%</font>. Yatra Online (NASDAQ:<a href='https://seekingalpha.com/symbol/YTRA' title='Yatra Online, Inc.'>YTRA</a>) <font color=\"green\">+37%</font>. Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Sciences Ltd.'>AXGT</a>) <font color=\"green\">+31%</font>. Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+27%</font>. Seres Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics, Inc.'>MCRB</a>) <font color=\"green\">+27%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware Inc.'>PHUN</a>) <font color=\"green\">+24%</font>. PolarityTE (NASDAQ:<a href='https://seekingalpha.com/symbol/PTE' title='PolarityTE, Inc.'>PTE</a>) <font color=\"green\">+23%</font>. DropCar (NASDAQ:<a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a>) <font color=\"green\">+23%</font>. Cellect Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a>) <font color=\"green\">+21%</font>.</li> <li><strong>Losers: </strong>AquaBounty Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a>) <font color=\"red\">-22%</font>. Diffusion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a>) <font color=\"red\">-19%</font>. Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"red\">-18%</font>. Pier 1 Imports (NYSE:<a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports, Inc.'>PIR</a>) <font color=\"red\">-16%</font>. Stellar Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies, Inc.'>SBOT</a>) <font color=\"red\">-15%</font>. Truett-Hurst (NASDAQ:<a href='https://seekingalpha.com/symbol/THST' title='Truett-Hurst, Inc.'>THST</a>) <font color=\"red\">-15%</font>. Care.com (NYSE:<a href='https://seekingalpha.com/symbol/CRCM' title='Care.com, Inc.'>CRCM</a>) <font color=\"red\">-13%</font>. GTx (NASDAQ:<a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a>) <font color=\"red\">-13%</font>. Quorum Health (NYSE:<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a>) <font color=\"red\">-12%</font>. Alliqua BioMedical (NASDAQ:<a href='https://seekingalpha.com/symbol/ALQA' title='Alliqua BioMedical, Inc.'>ALQA</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441546\" data-linked=\"Microcaps dominate midday movers\" data-tweet=\"$GLBS $ORGO $YTRA - Microcaps dominate midday movers https://seekingalpha.com/news/3441546-microcaps-dominate-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441546-microcaps-dominate-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441545\" data-ts=\"1552323765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441545-marine-petroleum-trust-leads-financial-gainers-jupai-holdings-and-u-s-global-investors-only\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marine Petroleum Trust leads financial gainers; Jupai Holdings and U.S. Global Investors only losers</a></h4><ul><li><b>Gainers:</b> Marine Petroleum Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/MARPS' title='Marine Petroleum Trust'>MARPS</a>) <font color=\"green\">+9%</font>. Banco Macro (NYSE:<a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a>) <font color=\"green\">+9%</font>. LM Funding America (NASDAQ:<a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a>) <font color=\"green\">+7%</font>. Yirendai (NYSE:<a href='https://seekingalpha.com/symbol/YRD' title='Yirendai Ltd.'>YRD</a>) <font color=\"green\">+7%</font>. PagSeguro Digital (NYSE:<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Jupai Holdings (NYSE:<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings Limited'>JP</a>) <font color=\"red\">-6%</font>. U.S. Global Investors (NASDAQ:<a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441545\" data-linked=\"Marine Petroleum Trust leads financial gainers; Jupai Holdings and U.S. Global Investors only losers\" data-tweet=\"$MARPS $BMA $LMFA - Marine Petroleum Trust leads financial gainers; Jupai Holdings and U.S. Global Investors only losers https://seekingalpha.com/news/3441545-marine-petroleum-trust-leads-financial-gainers-jupai-holdings-and-u-s-global-investors-only?source=tweet\" data-url=\"https://seekingalpha.com/news/3441545-marine-petroleum-trust-leads-financial-gainers-jupai-holdings-and-u-s-global-investors-only\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441542\" data-ts=\"1552323358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YPF\" target=\"_blank\">YPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441542-ypf-expects-production-decline-in-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YPF expects further production decline in 2019</a></h4><ul><li>YPF (<a href='https://seekingalpha.com/symbol/YPF' title='YPF Sociedad Anonima'>YPF</a> <font color='green'>+5.2%</font>) says it <a href=\"https://www.argusmedia.com/en/news/1862490-ypf-foresees-further-production-decline-in-2019\" target=\"_blank\">foresees a 2%-3% decline in 2019 production</a>, extending a downward trend that the company has been unable to shake off with rising shale flows.</li><li>The anticipated production decline to 483K-488K boe/day this year partly reflects insufficient domestic gas demand and excess supply, says YPF CEO Daniel Gonzalez.</li><li>Without periodic shut-ins related to weak demand, the company says it would have registered an additional 2.5M boe/day of production, meaning that total 2018 output would have been flat Y/Y.</li><li>YPF says it is exploring options to increase gas exports to neighboring Chile and  is working on getting a liquefaction barge into operation by Q3.</li><li>Long term, YPF is analyzing the feasibility of setting up a large-scale  LNG export terminal \"as part of a consortium that has yet to be put in  place,\" Gonzalez says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441542\" data-linked=\"YPF expects further production decline in 2019\" data-tweet=\"$YPF - YPF expects further production decline in 2019 https://seekingalpha.com/news/3441542-ypf-expects-production-decline-in-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3441542-ypf-expects-production-decline-in-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441540\" data-ts=\"1552322978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441540-caesarsplus-2-after-new-icahn-purchases\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caesars +2% after new Icahn purchases</a></h4><ul> <li>Shares of Caesars Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment Corporation'>CZR</a>) is <font color=\"green\">up 1.65%</font> after a new SEC filing indicates that Carl Icahn increased his stake in the casino company to 17.75% from 15.53% with a new round of purchases.</li><li>Icahn's stake includes some convertible bonds.</li> <li><a href=\"https://seekingalpha.com/filing/4398002\" target=\"_blank\">SEC Form 13D/A</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3441540\" data-linked=\"Caesars +2% after new Icahn purchases\" data-tweet=\"$CZR - Caesars +2% after new Icahn purchases https://seekingalpha.com/news/3441540-caesarsplus-2-after-new-icahn-purchases?source=tweet\" data-url=\"https://seekingalpha.com/news/3441540-caesarsplus-2-after-new-icahn-purchases\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441530\" data-ts=\"1552320791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441530-tech-sector-recovers-on-upgrades-mellanox-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech sector recovers on upgrades, Mellanox deal</a></h4><ul><li>The tech sector <font color=\"green\">gains 2.1%</font> as it recovers from last week's overall market weakness. Top stories of the day include analyst upgrades for <a href=\"https://seekingalpha.com/news/3441357-apple-plus-1_7-percent-bofa-sees-opportunity\" target=\"_blank\">Apple</a> and <a href=\"https://seekingalpha.com/news/3441369-nomura-upgrades-facebook-stories-transition\" target=\"_blank\">Facebook</a>, a double-notch downgrade for <a href=\"https://seekingalpha.com/news/3441420-oracle-minus-1_9-percent-double-downgrade\" target=\"_blank\">Oracle</a>, and Nvidia's <a href=\"https://seekingalpha.com/news/3441381-nvidia-acquires-mellanox-6_9b\" target=\"_blank\">$6.9B purchase</a> offer for Mellanox.</li><li>The Philadelphia Semiconductor Index is <font color=\"green\">up 2.3%</font> and the tech-heavy Nasdaq 100 <font color=\"green\">gains 1.9%</font>. The S&amp;P 500 is <font color=\"green\">up 1.1%</font>.</li><li>Related broad tech ETFs: <a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>, <a href='https://seekingalpha.com/symbol/VGT' title='Vanguard Information Technology ETF'>VGT</a>, <a href='https://seekingalpha.com/symbol/TECL' title='Direxion Technology Bull 3x Shares ETF'>TECL</a>, <a href='https://seekingalpha.com/symbol/FTEC' title='Fidelity MSCI Information Technology Index ETF'>FTEC</a>, <a href='https://seekingalpha.com/symbol/IYW' title='iShares U.S. Technology ETF'>IYW</a>, <a href='https://seekingalpha.com/symbol/ROM' title='ProShares Ultra Technology ETF'>ROM</a>, <a href='https://seekingalpha.com/symbol/QTEC' title='First Trust NASDAQ-100-Tech Index ETF'>QTEC</a>, <a href='https://seekingalpha.com/symbol/RYT' title='Invesco S&P 500 Equal Weight Technology ETF'>RYT</a>, <a href='https://seekingalpha.com/symbol/FNG' title='AdvisorShares New Tech and Media ETF'>FNG</a>, <a href='https://seekingalpha.com/symbol/TECS' title='Direxion Technology Bear 3x Shares ETF'>TECS</a>, <a href='https://seekingalpha.com/symbol/IGM' title='iShares North American Tech ETF'>IGM</a>, <a href='https://seekingalpha.com/symbol/FXL' title='First Trust Tech AlphaDEX ETF'>FXL</a>, <a href='https://seekingalpha.com/symbol/XNTK' title='SPDR NYSE Technology ETF'>XNTK</a>, <a href='https://seekingalpha.com/symbol/REW' title='ProShares UltraShort Technology ETF'>REW</a>, <a href='https://seekingalpha.com/symbol/JHMT' title='John Hancock Multifactor Technology ETF'>JHMT</a>, <a href='https://seekingalpha.com/symbol/XITK' title='SPDR Innovative Technology ETF'>XITK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3441530\" data-linked=\"Tech sector recovers on upgrades, Mellanox deal\" data-tweet=\"$XLK $VGT $TECL - Tech sector recovers on upgrades, Mellanox deal https://seekingalpha.com/news/3441530-tech-sector-recovers-on-upgrades-mellanox-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3441530-tech-sector-recovers-on-upgrades-mellanox-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441525\" data-ts=\"1552320119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441525-clear-channelplus-3-barrington-raises-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clear Channel +3% as Barrington raises to Buy</a></h4><ul>   <li>Clear Channel Outdoor Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CCO' title='Clear Channel Outdoor Holdings, Inc.'>CCO</a>) is <font color=\"green\">up 3%</font> after a boost to Outperform at Barrington Research.</li>    <li>The firm points to an upcoming separation from iHeartMedia (<a href='https://seekingalpha.com/symbol/IHRTQ' title='iHeartMedia, Inc.'>OTCPK:IHRTQ</a>) as well as potential upside from a REIT conversion, or from divesting the international business.</li>    <li>The firm has a $6.50 price target, implying 24% upside from current pricing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441525\" data-linked=\"Clear Channel +3% as Barrington raises to Buy\" data-tweet=\"$CCO $IHRT - Clear Channel +3% as Barrington raises to Buy https://seekingalpha.com/news/3441525-clear-channelplus-3-barrington-raises-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3441525-clear-channelplus-3-barrington-raises-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441524\" data-ts=\"1552320108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441524-new-age-beverages-and-turning-point-brands-among-consumer-gainers-kewaunee-scientific-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages and Turning Point Brands among consumer gainers; Kewaunee Scientific and Truett-Hurst in losers</a></h4><ul><li><b>Gainers: </b>Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"green\">+15%</font>. Fuling Global (NASDAQ:<a href='https://seekingalpha.com/symbol/FORK' title='Fuling Global Inc.'>FORK</a>) <font color=\"green\">+7%</font>. Turning Point Brands (NYSE:<a href='https://seekingalpha.com/symbol/TPB' title='Turning Point Brands, Inc.'>TPB</a>) <font color=\"green\">+5%</font>. New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"green\">+5%</font>. Berry Global Group (NYSE:<a href='https://seekingalpha.com/symbol/BERY' title='Berry Global Group, Inc.'>BERY</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Kewaunee Scientific (NASDAQ:<a href='https://seekingalpha.com/symbol/KEQU' title='Kewaunee Scientific Corporation'>KEQU</a>) <font color=\"red\">-12%</font>. Truett-Hurst (NASDAQ:<a href='https://seekingalpha.com/symbol/THST' title='Truett-Hurst, Inc.'>THST</a>) <font color=\"red\">-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441524\" data-linked=\"New Age Beverages and Turning Point Brands among consumer gainers; Kewaunee Scientific and Truett-Hurst in losers\" data-tweet=\"$FFHL $FORK $TPB - New Age Beverages and Turning Point Brands among consumer gainers; Kewaunee Scientific and Truett-Hurst in losers https://seekingalpha.com/news/3441524-new-age-beverages-and-turning-point-brands-among-consumer-gainers-kewaunee-scientific-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3441524-new-age-beverages-and-turning-point-brands-among-consumer-gainers-kewaunee-scientific-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441523\" data-ts=\"1552319894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441523-boeing-pares-big-losses-shares-now-down-5_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing pares big losses; shares now down 5.6%</a></h4><ul><li>Boeing (NYSE:<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>) shares <a href=\"https://www.wsj.com/articles/boeing-investors-need-history-lesson-after-crash-11552316380\" target=\"_blank\">continue</a> to pare heavy losses, with the stock most recently <font color=\"red\">down 5.6%</font> to $398.52 (after <font color=\"red\">falling as much as 13%</font>).</li><li>Besides a research note from Buckingham, which doesn't expect a big impact from the second 737 MAX 8 crash, \"lessons from history show that such accidents do surprisingly little damage to the business of selling aircraft,\" Jon Sindreu writes in <i>WSJ</i>.</li><li>\"In 2013, Boeing faced a big disruption when the FAA halted all flights using its 787 Dreamliner, which was then state of the art, following several incidents and emergency landings caused by the plane\u2019s faulty lithium-ion batteries. The jets stayed grounded for four months while Boeing designed a fix and waited for a green light from regulators. Boeing\u2019s shares lagged the broader stock market for a couple of months, but by the time the problem was fixed they had already more than made up for the underperformance. For the whole of 2013, Boeing stock rose 81%, far ahead of the S&amp;P 500.\"</li><li>\"Airlines are also unlikely to turn away its latest iteration, even if it needs an expensive overhaul. The Lion Air accident doesn\u2019t seem to have affected Boeing\u2019s order book.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3441523\" data-linked=\"Boeing pares big losses; shares now down 5.6%\" data-tweet=\"$BA - Boeing pares big losses; shares now down 5.6% https://seekingalpha.com/news/3441523-boeing-pares-big-losses-shares-now-down-5_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3441523-boeing-pares-big-losses-shares-now-down-5_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441522\" data-ts=\"1552319807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XPO\" target=\"_blank\">XPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441522-xpo-logistics-rallies-after-s-and-p-index-inclusion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XPO Logistics rallies after S&amp;P index inclusion</a></h4><ul> <li>XPO Logistics (NYSE:<a href='https://seekingalpha.com/symbol/XPO' title='XPO Logistics, Inc.'>XPO</a>) <font color=\"green\">jumps 7.65%</font> after S&amp;P Dow Jones announces that the company is a new addition to the S&amp;P MidCap 400 Index.</li> <li>Shares of XPO came within pennies of cracking $50 for the first time since February 28.</li> <li><a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/887759_xpobigdrill46.pdf?force_download=true\" target=\"_blank\">S&amp;P press release</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3441522\" data-linked=\"XPO Logistics rallies after S&amp;P index inclusion\" data-tweet=\"$XPO - XPO Logistics rallies after S&amp;P index inclusion https://seekingalpha.com/news/3441522-xpo-logistics-rallies-after-s-and-p-index-inclusion?source=tweet\" data-url=\"https://seekingalpha.com/news/3441522-xpo-logistics-rallies-after-s-and-p-index-inclusion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441520\" data-ts=\"1552319639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZG\" target=\"_blank\">ZG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441520-zillowplus-2-on-craig-hallums-ibuyer-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow +2% on Craig-Hallum&#39;s iBuyer optimism</a></h4><ul><li>Craig-Hallum analyst Brad Berning says Zillow (NASDAQ:<a href='https://seekingalpha.com/symbol/ZG' title='Zillow Group, Inc.'>ZG</a>) investors should only ask themselves if the iBuyer business will be \"Big or Really Big.\"</li><li>The analyst expects Zillow and Opentable to lead the web-based home flipping market and to \"capture rapid market share\" in 2019 and 2020.</li><li>The firm maintains its Street-high $50 price target.</li><li>ZG is<font color=\"green\"> up 2.2%</font> to $38.68.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441520\" data-linked=\"Zillow +2% on Craig-Hallum&#39;s iBuyer optimism\" data-tweet=\"$ZG - Zillow +2% on Craig-Hallum&#39;s iBuyer optimism https://seekingalpha.com/news/3441520-zillowplus-2-on-craig-hallums-ibuyer-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/3441520-zillowplus-2-on-craig-hallums-ibuyer-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441515\" data-ts=\"1552318046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INS\" target=\"_blank\">INS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441515-intelligent-systemsplus-6_2-amid-news-of-goldman-pact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelligent Systems +6.2% amid news of Goldman pact</a></h4><ul><li>Intelligent Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/INS' title='Intelligent Systems Corporation'>INS</a>)<font color=\"green\"> surges 6.2%</font> after Bloomberg reports that the company's CoreCard Software unit<a href=\"https://www.bloomberg.com/news/articles/2019-03-11/goldman-s-apple-card-said-to-land-big-win-for-tiny-georgia-firm?utm_source=twitter&amp;utm_medium=social&amp;cmpid=socialflow-twitter-business&amp;utm_content=business&amp;utm_campaign=socialflow-organic\" target=\"_blank\"> entered into a licensing agreement</a> with Goldman Sachs (<a href='https://seekingalpha.com/symbol/GS' title='The Goldman Sachs Group, Inc.'>GS</a> <font color='green'>+1.1%</font>) last year.</li><li>Goldman picked the little known firm, CoreCard Software, to  help handle payments for its planned credit-card partnership with Apple, Bloomberg reports, citing a person with knowledge of the matter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3435548-apple-goldman-plan-credit-card-pairs-iphone-features-wsj\" target=\"_blank\">Apple and Goldman plan credit card that pairs with iPhone features: WSJ</a> (Feb. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441515\" data-linked=\"Intelligent Systems +6.2% amid news of Goldman pact\" data-tweet=\"$INS $GS - Intelligent Systems +6.2% amid news of Goldman pact https://seekingalpha.com/news/3441515-intelligent-systemsplus-6_2-amid-news-of-goldman-pact?source=tweet\" data-url=\"https://seekingalpha.com/news/3441515-intelligent-systemsplus-6_2-amid-news-of-goldman-pact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441511\" data-ts=\"1552317481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBIX\" target=\"_blank\">EBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441511-yatraplus-38-on-ebix-buyout-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yatra +38% on Ebix buyout offer</a></h4><ul><li>Ebix (NASDAQ:<a href='https://seekingalpha.com/symbol/EBIX' title='Ebix, Inc.'>EBIX</a>) is<a href=\"https://seekingalpha.com/pr/17439767-ebix-offers-acquire-india-s-largest-corporate-travel-exchange-yatra-online-inc\" target=\"_blank\"> offering</a> to buy Indian travel services company Yatra Online (NASDAQ:<a href='https://seekingalpha.com/symbol/YTRA' title='Yatra Online, Inc.'>YTRA</a>) for $336M in cash and stock.</li><li>The $7/share offer price is a 84% premium to Yatra's Friday close. But Ebix says it may reduce the offer if it doesn't receive a positive response from Yatra's board. Ebix could withdraw the offer if Yatra doesn't let due diligence start by March 18.</li><li>Ebix wants to merge Yatra into its Indian EbixCash subsidiary and expects the deal to add $0.25 to $0.30 for shareholders of the combined company.</li><li>Ebix shares are <font color=\"green\">up 1.1%</font> and Yatra <font color=\"green\">gains 38.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441511\" data-linked=\"Yatra +38% on Ebix buyout offer\" data-tweet=\"$EBIX $YTRA - Yatra +38% on Ebix buyout offer https://seekingalpha.com/news/3441511-yatraplus-38-on-ebix-buyout-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3441511-yatraplus-38-on-ebix-buyout-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441510\" data-ts=\"1552317208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCII\" target=\"_blank\">RCII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441510-rent-centerplus-3-vintage-hearing-wraps-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rent-A-Center +3% as Vintage hearing wraps up</a></h4><ul> <li>Rent-A-Center (NASDAQ:<a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center, Inc.'>RCII</a>) is <font color=\"green\">up 3.05%</font> with the company's attorneys in court today battling Vintage Capital over the terminated merger.</li> <li>Bloomberg reports the hearing is wrapping up with closing arguments being presented by both sides.</li> <li>Shares of RCII are at $21.19 vs. the $15 deal price originally struck with Vintage.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441510\" data-linked=\"Rent-A-Center +3% as Vintage hearing wraps up\" data-tweet=\"$RCII - Rent-A-Center +3% as Vintage hearing wraps up https://seekingalpha.com/news/3441510-rent-centerplus-3-vintage-hearing-wraps-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3441510-rent-centerplus-3-vintage-hearing-wraps-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441506\" data-ts=\"1552316624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441506-seres-therapeutics-and-tonix-pharmaceuticals-among-healthcare-gainers-quorum-health-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seres Therapeutics and Tonix Pharmaceuticals among healthcare gainers; Quorum Health and Stellar Biotechnologies among the losers</a></h4><ul><li><b>Gainers: </b>Seres Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics, Inc.'>MCRB</a>) <font color=\"green\">+51%</font>. Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Sciences Ltd.'>AXGT</a>) <font color=\"green\">+41%</font>. Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+36%</font>. Cellect Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a>) <font color=\"green\">+28%</font>. Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"green\">+19%</font>.</li><li><b>Losers: </b>AquaBounty Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a>) <font color=\"red\">-25%</font>. Stellar Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies, Inc.'>SBOT</a>) <font color=\"red\">-19%</font>. Quorum Health (NYSE:<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a>) <font color=\"red\">-18%</font>. Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"red\">-18%</font>. Alliqua BioMedical (NASDAQ:<a href='https://seekingalpha.com/symbol/ALQA' title='Alliqua BioMedical, Inc.'>ALQA</a>) <font color=\"red\">-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441506\" data-linked=\"Seres Therapeutics and Tonix Pharmaceuticals among healthcare gainers; Quorum Health and Stellar Biotechnologies among the losers\" data-tweet=\"$MCRB $AXGT $BPTH - Seres Therapeutics and Tonix Pharmaceuticals among healthcare gainers; Quorum Health and Stellar Biotechnologies among the losers https://seekingalpha.com/news/3441506-seres-therapeutics-and-tonix-pharmaceuticals-among-healthcare-gainers-quorum-health-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3441506-seres-therapeutics-and-tonix-pharmaceuticals-among-healthcare-gainers-quorum-health-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441504\" data-ts=\"1552316412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRCM\" target=\"_blank\">CRCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441504-care-comminus-13-on-wsj-report-on-caregiver-screening\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Care.com -13% on WSJ report on caregiver screening</a></h4><ul><li>Care.com (NYSE:<a href='https://seekingalpha.com/symbol/CRCM' title='Care.com, Inc.'>CRCM</a>) <font color=\"red\">plunges 13.3%</font> on Friday's after hours <a href=\"https://www.wsj.com/articles/care-com-puts-onus-on-families-to-check-caregivers-backgroundswith-sometimes-tragic-outcomes-11552088138\" target=\"_blank\">WSJ report </a>critical of the company's caregiver screening practices, which have led to \"tragic outcomes.\"</li><li>BTIG says the report poses more of a \"reputational than legal\" risk to the company and notes that CRCM \"is clear in its customer communications that it does not verify what caregivers say about themselves.\"</li><li>BTIG thinks Care.com should focus on shortening the notification windows once it finds out a caregiver has a police record and make its alerts \"highly prominent.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3441504\" data-linked=\"Care.com -13% on WSJ report on caregiver screening\" data-tweet=\"$CRCM - Care.com -13% on WSJ report on caregiver screening https://seekingalpha.com/news/3441504-care-comminus-13-on-wsj-report-on-caregiver-screening?source=tweet\" data-url=\"https://seekingalpha.com/news/3441504-care-comminus-13-on-wsj-report-on-caregiver-screening\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441503\" data-ts=\"1552316012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRTX\" target=\"_blank\">HRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441503-herons-htxminus-011-shows-treatment-benefit-in-postop-pain-study-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron&#39;s HTX-011 shows treatment benefit in postop pain study; shares up 1%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17439502-77-percent-patients-remain-opioid-free-htxminus-011-given-counter-analgesic-regimen-new-multi\" target=\"_blank\">Results </a>from a postoperative pain study evaluating Heron Therapeutics' (<a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color=\"green\">+0.7%</font>) HTX-011, together with an oral regimen of over-the-counter &#40;OTC&#41; painkillers acetaminophen and ibuprofen, for the management of postoperative pain in patients who had a bunion removed (bunionectomy) showed a significant treatment benefit.</li><li>77% of patients receiving the combo regimen did not require opioids for their pain through 72 hours post-surgery, well above 29%, 11% and 2%, respectively, for HTX-011 alone, bupivacaine and placebo. All opioid-free patients in the treatment group remained so through 28 days after surgery.</li><li>The company's U.S. marketing application seeking approval for HTX-011 for treating postoperative pain is currently under FDA review with an action date of April 30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441503\" data-linked=\"Heron&#39;s HTX-011 shows treatment benefit in postop pain study; shares up 1%\" data-tweet=\"$HRTX - Heron&#39;s HTX-011 shows treatment benefit in postop pain study; shares up 1% https://seekingalpha.com/news/3441503-herons-htxminus-011-shows-treatment-benefit-in-postop-pain-study-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3441503-herons-htxminus-011-shows-treatment-benefit-in-postop-pain-study-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441502\" data-ts=\"1552315786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDB\" target=\"_blank\">MDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441502-mongodb-backs-off-unpopular-license-mdbplus-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MongoDB backs off unpopular license; MDB +4%</a></h4><ul><li>MongoDB (NASDAQ:<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a>) pulls its Server Side Public License &#40;SSPL&#41; from consideration at the Open Source Initiative, according to post from <a href=\"http://lists.opensource.org/pipermail/license-review_lists.opensource.org/2019-March/003989.html\" target=\"_blank\">CTO Eliot Horowitz</a>.</li><li>Key quote: \"We continue to believe that the SSPL complies with the Open Source Definition and the four essential software freedoms.  However, based on its reception by the members of this list and the greater open source community, the community consensus required to support OSI approval does not currently appear to exist regarding the copyleft provision of SSPL. Thus, in order to be respectful of the time and efforts of the OSI board and this list\u2019s members, we are hereby withdrawing the SSPL from OSI consideration.\"</li><li>MongoDB <a href=\"https://seekingalpha.com/news/3397694-mongodb-issues-new-open-source-license\" target=\"_blank\">announced </a>the SSPL in October as a way to hit back at cloud providers using its open source code in a commercialized product without passing on open source benefits to users. Red Hat <a href=\"https://seekingalpha.com/news/3423606-red-hat-drops-mongodb-sspl-mdb-minus-3-percent\" target=\"_blank\">responded </a>by removing MDB from its Enterprise Linux and Fedora Linux distribution. Amazon <a href=\"https://seekingalpha.com/news/3422037-amazon-comes-mongodb-mdb-minus-15-percent\" target=\"_blank\">launched </a>the DocumentDB managed database that was compatible with MongoDB versions that predate the SSPL license.</li><li>MDB shares are <font color=\"green\">up 4.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441502\" data-linked=\"MongoDB backs off unpopular license; MDB +4%\" data-tweet=\"$MDB - MongoDB backs off unpopular license; MDB +4% https://seekingalpha.com/news/3441502-mongodb-backs-off-unpopular-license-mdbplus-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3441502-mongodb-backs-off-unpopular-license-mdbplus-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441499\" data-ts=\"1552315637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441499-transocean-offshore-oil-drilling-stocks-are-bargains-barrons\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean, offshore oil drilling stocks are bargains - Barron&#39;s</a></h4><ul><li>Offshore oil drilling stocks enjoy a <em>Barron's</em> bounce after the publication profiled the sector over the weekend and cited <a href=\"https://www.barrons.com/articles/offshore-oil-drilling-stocks-are-energy-bargains-51552093202\" target=\"_blank\">signs of a turnaround</a>, including a 28% Y/Y increase in the worldwide offshore rig count through February.</li><li>Evercore ISI analyst James West favors Transocean (<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='green'>+2.7%</font>), which he calls \"the best-managed company in the group\" and enjoys \"plenty of room for improvement\" after its December purchase of Ocean Rig UDW.</li><li>West also likes Ensco (<a href='https://seekingalpha.com/symbol/ESV' title='Ensco plc'>ESV</a> <font color='green'>+0.5%</font>) and Rowan (<a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a> <font color='green'>+0.2%</font>) - which are merging - and Diamond Offshore Drilling (<a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling, Inc.'>DO</a> <font color='green'>+2.5%</font>).</li><li>Graeme Forster, who manages international equity strategy at Orbis Investment Management, also has taken positions in RIG, ESV and DO, and notes \"you\u2019re never going to fulfill all the world\u2019s energy needs from shale.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3441499\" data-linked=\"Transocean, offshore oil drilling stocks are bargains - Barron&#39;s\" data-tweet=\"$RIG $ESV $RDC - Transocean, offshore oil drilling stocks are bargains - Barron&#39;s https://seekingalpha.com/news/3441499-transocean-offshore-oil-drilling-stocks-are-bargains-barrons?source=tweet\" data-url=\"https://seekingalpha.com/news/3441499-transocean-offshore-oil-drilling-stocks-are-bargains-barrons\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441491\" data-ts=\"1552314489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TENX\" target=\"_blank\">TENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441491-tenax-down-6-on-start-of-mid-stage-study-of-levosimendan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenax down 6% on start of mid-stage study of levosimendan</a></h4><ul><li>Investors appear unmoved with the start of enrollment in a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03541603?lead=tenax&amp;phase=1&amp;rank=2\" target=\"_blank\">HELP</a>, evaluating Tenax Therapeutics' (<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a> <font color=\"red\">-5.6%</font>) lead drug levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF).</li><li>The primary endpoint of the 36-subject study is the change from baseline in Pulmonary Capillary Wedge Pressure &#40;PCWP&#41; with bicycle exercise at week 6.</li><li>The estimated primary completion date is November.</li><li>The company acquired the North American rights to the calcium sensitizer from Phyxius Pharma in 2013.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441491\" data-linked=\"Tenax down 6% on start of mid-stage study of levosimendan\" data-tweet=\"$TENX - Tenax down 6% on start of mid-stage study of levosimendan https://seekingalpha.com/news/3441491-tenax-down-6-on-start-of-mid-stage-study-of-levosimendan?source=tweet\" data-url=\"https://seekingalpha.com/news/3441491-tenax-down-6-on-start-of-mid-stage-study-of-levosimendan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441488\" data-ts=\"1552313879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRMB\" target=\"_blank\">TRMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441488-trimble-announces-video-intelligence-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trimble announces Video Intelligence deal</a></h4><ul><li>Trimble (NASDAQ:<a href='https://seekingalpha.com/symbol/TRMB' title='Trimble Inc.'>TRMB</a>) <a href=\"https://seekingalpha.com/pr/17439308-fortune-transportation-selects-trimbles-video-intelligence-improve-safety-liability\" target=\"_blank\">announces</a> that refrigerated carrier company Fortune Transportation is deploying the Trimble Video Intelligence solution in its 135 trucks.</li><li>Minnesota-based Fortune has been a Trimble customer since 2017.</li><li>Trimble shares are <font color=\"green\">up 0.7%</font> to $38.40.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441488\" data-linked=\"Trimble announces Video Intelligence deal\" data-tweet=\"$TRMB - Trimble announces Video Intelligence deal https://seekingalpha.com/news/3441488-trimble-announces-video-intelligence-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3441488-trimble-announces-video-intelligence-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441486\" data-ts=\"1552313590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441486-tonix-up-19-on-new-tonyma-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix up 19% on new Tonyma study</a></h4><ul><li>Nano cap Tonix Pharmaceuticals (<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color=\"green\">+19.3%</font>) is up on almost a 10x surge in volume in reaction to the start of <a href=\"https://seekingalpha.com/pr/17439221-tonix-pharmaceuticals-enrolls-first-participant-recovery-study-new-phase-3-trial-tonmya\" target=\"_blank\">enrollment </a>in a new Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03841773?lead=tonix&amp;phase=2&amp;rank=1\" target=\"_blank\">RECOVERY</a>, evaluating Tonmya (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the treatment of posttraumatic stress disorder &#40;PTSD&#41;.</li><li>The primary endpoint is the mean change from baseline in a PTSD symptom scale called CAPS-5 at various time points versus placebo, including week 4 which was the best performing subgroup in a previous unsuccessful late-stage study. CAPS-5 was the metric used to support U.S. approval of two currently marketed PTSD treatments.</li><li>In the summer of 2018, shares plummeted when the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03062540?lead=tonix&amp;phase=2&amp;rank=4\" target=\"_blank\">HONOR</a> trial failed to achieve the primary endpoint, mean CAPS-5 change from baseline at week 12. At that time, the company said it intended to design another study.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441486\" data-linked=\"Tonix up 19% on new Tonyma study\" data-tweet=\"$TNXP - Tonix up 19% on new Tonyma study https://seekingalpha.com/news/3441486-tonix-up-19-on-new-tonyma-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3441486-tonix-up-19-on-new-tonyma-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441484\" data-ts=\"1552313458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441484-ibm-collabs-on-credit-union-blockchain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM collabs on credit union blockchain</a></h4><ul><li>IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) and credit union service organization CULedger <a href=\"https://seekingalpha.com/pr/17439329-culedger-ibm-announce-collaboration-deliver-blockchain-services-financial-cooperatives-credit\" target=\"_blank\">announce</a> a collaboration for new blockchain-based services to create an \"immutable audit trail that can be used to create new business models and transform existing business processes for credit unions.\"</li><li>CULedge expects the permissioned blockchain services to be available to credit union members worldwide later this year.</li><li>IBM shares are <font color=\"green\">up 1.6%</font> to $137.27.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441484\" data-linked=\"IBM collabs on credit union blockchain\" data-tweet=\"$IBM - IBM collabs on credit union blockchain https://seekingalpha.com/news/3441484-ibm-collabs-on-credit-union-blockchain?source=tweet\" data-url=\"https://seekingalpha.com/news/3441484-ibm-collabs-on-credit-union-blockchain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441483\" data-ts=\"1552313373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLGG\" target=\"_blank\">SLGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441483-super-league-gamingplus-8_5-national-securities-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Super League Gaming +8.5% as National Securities starts at Buy</a></h4><ul>   <li>Super League Gaming (NASDAQ:<a href='https://seekingalpha.com/symbol/SLGG' title='Super League Gaming, Inc.'>SLGG</a>) is <font color=\"green\">up 8.5%</font> after an initiation at Buy by National Securities.</li>    <li>The amateur esports community is still below its IPO price of $11, now quoting at $8.81.</li>     <li>Shares are <font color=\"red\">down 9.7%</font> over the past week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441483\" data-linked=\"Super League Gaming +8.5% as National Securities starts at Buy\" data-tweet=\"$SLGG - Super League Gaming +8.5% as National Securities starts at Buy https://seekingalpha.com/news/3441483-super-league-gamingplus-8_5-national-securities-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3441483-super-league-gamingplus-8_5-national-securities-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441476\" data-ts=\"1552312498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOS\" target=\"_blank\">KTOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441476-kratos-receives-7_7m-c5isr-awards\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kratos receives $7.7M C5ISR awards</a></h4><ul><li>Kratos Defense &amp; Security Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/KTOS' title='Kratos Defense & Security Solutions, Inc.'>KTOS</a>) <a href=\"https://seekingalpha.com/pr/17439645-kratos-receives-7_7-million-c5isr-system-program-awards\" target=\"_blank\">announces</a> receiving $7.7M in Command, Control, Communication, Computing, Combat and Intelligence Surveillance and Reconnaissance program awards. Additional details not provided for security reasons. </li><li>KTOS shares are <font color=\"red\">down 1%</font> to $16.11.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441476\" data-linked=\"Kratos receives $7.7M C5ISR awards\" data-tweet=\"$KTOS - Kratos receives $7.7M C5ISR awards https://seekingalpha.com/news/3441476-kratos-receives-7_7m-c5isr-awards?source=tweet\" data-url=\"https://seekingalpha.com/news/3441476-kratos-receives-7_7m-c5isr-awards\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441470\" data-ts=\"1552312130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCRB\" target=\"_blank\">MCRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441470-seres-teams-up-astrazeneca-in-cancer-shares-up-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seres teams up with AstraZeneca in cancer; shares up 17%</a></h4><ul><li>Thinly traded micro cap Seres Therapeutics (<a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics, Inc.'>MCRB</a> <font color=\"green\">+17.2%</font>) is up on average volume in early trade on the heels of its three-year research <a href=\"https://seekingalpha.com/pr/17439742-seres-therapeutics-announces-microbiome-immuno-oncology-focused-collaboration-astrazeneca\" target=\"_blank\">collaboration </a>with AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a> <font color=\"green\">+0.4%</font>) aimed at advancing the understanding of how the microbiome may boost the effectiveness of cancer immunotherapy, including potential synergy with AZN compounds.</li><li>The partnership will assess microbiome-based approaches as a predictor for suitable patients for certain cancer immunotherapies. The parties also plan to evaluate the combination of SER-401 with AZN drugs in a range of cancers.</li><li>Under the terms of the agreement, AZN will pay MCRB $20M in three installments over two-years with the first payment due at signing. AZN will reimburse MCRB for research activities and will have the option to negotiate for rights to the programs and other discoveries from the collaboration. MCRB will maintain its rights to oncology-targeted microbiome candidates.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441470\" data-linked=\"Seres teams up with AstraZeneca in cancer; shares up 17%\" data-tweet=\"$MCRB $MCRB $AZN - Seres teams up with AstraZeneca in cancer; shares up 17% https://seekingalpha.com/news/3441470-seres-teams-up-astrazeneca-in-cancer-shares-up-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3441470-seres-teams-up-astrazeneca-in-cancer-shares-up-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441468\" data-ts=\"1552311851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441468-chinese-media-stocks-launch-rally-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese media stocks launch rally in U.S.</a></h4><ul>   <li>Media stocks are pacing the gains for an early surge in U.S.-traded Chinese issues, following a resumed stock rally in Chinese markets.</li>    <li>Weibo (NASDAQ:<a href='https://seekingalpha.com/symbol/WB' title='Weibo Corporation'>WB</a>) is <font color=\"green\">up 2.6%</font> (and <a href='https://seekingalpha.com/symbol/SINA' title='SINA Corporation'>SINA</a> <font color=\"green\">up 2.2%</font>) out of today's U.S. open. Sohu.com (NASDAQ:<a href='https://seekingalpha.com/symbol/SOHU' title='Sohu.com Limited'>SOHU</a>) is <font color=\"green\">up 3.5%</font>, Sogou (NYSE:<a href='https://seekingalpha.com/symbol/SOGO' title='Sogou Inc.'>SOGO</a>) <font color=\"green\">up 2.4%</font>.</li>    <li><a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> is <font color=\"green\">up 2%</font>; Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo Inc.'>MOMO</a>) <font color=\"green\">up 2.2%</font>.</li>    <li>Meanwhile, iQiyi (NASDAQ:<a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc.'>IQ</a>) is <font color=\"green\">up 2.8%</font>; Huya Broadcasting (NYSE:<a href='https://seekingalpha.com/symbol/HUYA' title='HUYA Inc.'>HUYA</a>) <font color=\"green\">up 6.3%</font>; NetEase (NASDAQ:<a href='https://seekingalpha.com/symbol/NTES' title='NetEase, Inc.'>NTES</a>) is <font color=\"green\">up 2.5%</font>. In OTC trading, Tencent (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holdings Limited'>OTCPK:TCEHY</a>) was <font color=\"green\">up 3.3%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441468\" data-linked=\"Chinese media stocks launch rally in U.S.\" data-tweet=\"$WB $SINA $SOHU - Chinese media stocks launch rally in U.S. https://seekingalpha.com/news/3441468-chinese-media-stocks-launch-rally-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3441468-chinese-media-stocks-launch-rally-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441458\" data-ts=\"1552310817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLNX\" target=\"_blank\">XLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441458-xilinx-intel-gain-on-nvidias-mellanox-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xilinx, Intel gain on Nvidia&#39;s Mellanox buy</a></h4><ul><li>Xilinx (NASDAQ:<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a>) <font color=\"green\">gains 1.3%</font> on the news that Nvidia is buying Mellanox for $6.9B. Xilinx was speculated to be among the potential buyers for MLNX.</li><li>Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>), another potential buyer that Nvidia outbid, is up <font color=\"green\">0.3%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441381-nvidia-acquires-mellanox-6_9b\" target=\"_blank\">Nvidia acquires Mellanox for $6.9B</a> (March 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441458\" data-linked=\"Xilinx, Intel gain on Nvidia&#39;s Mellanox buy\" data-tweet=\"$XLNX $INTC - Xilinx, Intel gain on Nvidia&#39;s Mellanox buy https://seekingalpha.com/news/3441458-xilinx-intel-gain-on-nvidias-mellanox-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3441458-xilinx-intel-gain-on-nvidias-mellanox-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441456\" data-ts=\"1552310722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXGT\" target=\"_blank\">AXGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441456-axovant-sciences-up-48-premarket-gene-therapy-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axovant Sciences up 48% premarket gene therapy data</a></h4><ul><li>Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Sciences Ltd.'>AXGT</a>) is up <a href=\"https://seekingalpha.com/pr/17439129-axovant-reports-positive-interim-results-first-cohort-sunrise-pd-phase-2-trial-axo-lenti-pd\" target=\"_blank\">48%</a> premarket on robust volume in reaction to positive data on two of its gene therapy candidates.</li><li><a href=\"https://seekingalpha.com/pr/17439129-axovant-reports-positive-interim-results-first-cohort-sunrise-pd-phase-2-trial-axo-lenti-pd\" target=\"_blank\">Three-month results</a> from AXO-Lenti-PD in Parkinson's disease patients (Phase 1/2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03720418?lead=axovant&amp;rank=1\" target=\"_blank\">SUNRISE-PD</a> study) showed a 55% average improvement from baseline in OFF score.</li><li><a href=\"https://seekingalpha.com/pr/17439127-axovant-announces-clinical-update-first-tay-sachs-disease-patient-dosed-axo-aav-gm2-gene\" target=\"_blank\">Three-month data </a>on AXO-AAV-GM2 in a patient with advanced infantile Tay-Sachs disease showed no serious adverse events and no clinical relevant laboratory abnormalities. The patient experienced stable disease from baseline to month 3 with no brain deterioration as measured by MRI.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441456\" data-linked=\"Axovant Sciences up 48% premarket gene therapy data\" data-tweet=\"$AXGT - Axovant Sciences up 48% premarket gene therapy data https://seekingalpha.com/news/3441456-axovant-sciences-up-48-premarket-gene-therapy-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3441456-axovant-sciences-up-48-premarket-gene-therapy-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441455\" data-ts=\"1552310656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441455-mlnx-tnxp-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MLNX, TNXP among premarket gainers</a></h4><ul><li>Globus Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Limited'>GLBS</a>) <font color=\"green\">+109%</font>.</li><li>Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Sciences Ltd.'>AXGT</a>) <font color=\"green\">+45%</font> on clinical <a href=\"https://seekingalpha.com/pr/17439127-axovant-announces-clinical-update-first-tay-sachs-disease-patient-dosed-axo-aav-gm2-gene\" target=\"_blank\">update</a> from first Tay-Sachs disease patient dosed with AXO-AAV-GM2 gene therapy.</li><li>Pyxis Tankers (NASDAQ:<a href='https://seekingalpha.com/symbol/PXS' title='Pyxis Tankers Inc.'>PXS</a>) <font color=\"green\">+43%</font>.</li><li>Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"green\">+28%</font> as first <a href=\"https://seekingalpha.com/pr/17439221-tonix-pharmaceuticals-enrolls-first-participant-recovery-study-new-phase-3-trial-tonmya\" target=\"_blank\">participant</a> was enrolled in the RECOVERY study, a new Phase 3 study of Tonmya.</li><li>PolarityTE (NASDAQ:<a href='https://seekingalpha.com/symbol/PTE' title='PolarityTE, Inc.'>PTE</a>) <font color=\"green\">+26%</font> ahead of its corporate <a href=\"https://seekingalpha.com/news/3441356-polarityte-12-percent-premarket-ahead-presentations\" target=\"_blank\">presentation</a>.</li><li>Cellect Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a>) <font color=\"green\">+19%</font> on <a href=\"https://seekingalpha.com/news/3441394-cellect-27-percent-positive-results-cell2in-collaboration\" target=\"_blank\">positive results</a> from Cell2in collaboration.</li><li>DropCar (NASDAQ:<a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a>) <font color=\"green\">+18%</font>.</li><li>Inpixon (NASDAQ:<a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a>) <font color=\"green\">+13%</font> on <a href=\"https://seekingalpha.com/pr/17439512-inpixon-receives-notice-allowance-u-s-patent-covering-faster-way-join-large-database-tables\" target=\"_blank\">receiving</a> a Notice of Allowance from the U.S. Patent and Trademark Office allowing its patent application covering techniques to expedite joins of large database tables.</li><li>ToughBuilt (NASDAQ:<a href='https://seekingalpha.com/symbol/TBLT' title='ToughBuilt Industries, Inc.'>TBLT</a>) <font color=\"green\">+12%</font> on <a href=\"https://seekingalpha.com/pr/17439689-toughbuilt-granted-two-new-u-s-design-patents-covering-ruggedized-mobile-devices\" target=\"_blank\">announcing</a> that USPTO has granted two new design patents that cover ToughBuilt's ruggedized mobile devices, which are valid for a period of 15 years.</li><li>SenesTech (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech, Inc.'>SNES</a>) <font color=\"green\">+12%</font> as ContraPest has <a href=\"https://seekingalpha.com/pr/17439687-hosted-trials-contrapest-poultry-production-facilities-results-commercial-deployment-central\" target=\"_blank\">completed initial trials</a> in hosted poultry farms and will begin first commercial application in egg production facilities in California's central valley.</li><li>TrovaGene (NASDAQ:<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>) <font color=\"green\">+11%</font>.</li><li>Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+9%</font>.</li><li>Mellanox Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNX' title='Mellanox Technologies, Ltd.'>MLNX</a>) <font color=\"green\">+9%</font> on being <a href=\"https://seekingalpha.com/news/3441381-nvidia-acquires-mellanox-6_9b\" target=\"_blank\">acquired</a> by Nvidia.</li><li>USA Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a>) <font color=\"green\">+9%</font>.</li><li>China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"green\">+8%</font>.</li><li>Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"green\">+8%</font>.</li><li>Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"green\">+6%</font>.</li><li>CHF Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a>) <font color=\"green\">+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441455\" data-linked=\"MLNX, TNXP among premarket gainers\" data-tweet=\"$GLBS $AXGT $PXS - MLNX, TNXP among premarket gainers https://seekingalpha.com/news/3441455-mlnx-tnxp-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441455-mlnx-tnxp-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441451\" data-ts=\"1552309842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WY\" target=\"_blank\">WY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441451-weyerhaeuserplus-1_1-bmo-boosts-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weyerhaeuser +1.1% as BMO boosts to outperform</a></h4><ul><li>Weyerhaeuser (NYSE:<a href='https://seekingalpha.com/symbol/WY' title='Weyerhaeuser Company'>WY</a>) <font color=\"green\">rises 1.1%</font> in premarket trading after BMO Capital Markets analyst Mark Wilde boosts his rating on the stock to outperform from market perform and says demand for wood should improve heading into the the spring construction season.</li><li>With lean inventories across the supply chain, \"improved demand should translate into stronger lumber prices,\" Wilde wrote.</li><li>Also, Weyerhaeuser,  trading \"well below our prudent $34/share estimate of net asset value,\" offers \"an attractive entry point.\"</li><li><a href=\"https://seekingalpha.com/symbol/WY/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428622-weyerhaeuser-minus-4_7-percent-q4-hurt-lower-wood-products-profit\" target=\"_blank\">Weyerhaeuser -4.7% after Q4 hurt by lower wood products profit</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441451\" data-linked=\"Weyerhaeuser +1.1% as BMO boosts to outperform\" data-tweet=\"$WY - Weyerhaeuser +1.1% as BMO boosts to outperform https://seekingalpha.com/news/3441451-weyerhaeuserplus-1_1-bmo-boosts-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3441451-weyerhaeuserplus-1_1-bmo-boosts-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441449\" data-ts=\"1552309731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441449-ba-and-aqb-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BA and AQB among premarket losers</a></h4><ul><li>AquaBounty Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a>) <font color=\"red\">-23%</font>.</li><li>The Boeing (NYSE:<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>) <font color=\"red\">-11%</font> as China <a href=\"https://seekingalpha.com/news/3441330-boeing-minus-9-percent-china-suspends-737-max-8-operations\" target=\"_blank\">suspends</a> 737 MAX 8 operations.</li><li>Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"red\">-11%</font>.</li><li>Stellar Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies, Inc.'>SBOT</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441449\" data-linked=\"BA and AQB among premarket losers\" data-tweet=\"$AQB $BA $SEEL - BA and AQB among premarket losers https://seekingalpha.com/news/3441449-ba-and-aqb-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441449-ba-and-aqb-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441439\" data-ts=\"1552309107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441439-bristol-myers-not-quite-in-convincing-shareholders-on-merits-of-celgene-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristol-Myers not quite there in convincing shareholders on merits of Celgene deal</a></h4><ul><li>Bristol-Myers Squibb (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) met with sell-side analysts on Friday, March 8, as part of its campaign to sell the merits of its announced $74B bid for Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>), a deal that lacks support from key shareholders.</li><li>According to Wolfe's Tim Anderson, there continues to be \"uneasiness\" among stockholders about the supposed benefits of the transaction and if BMY management can deliver on the projected upside.</li><li>There are apparently <a href=\"https://endpts.com/its-what-bristol-myers-execs-arent-saying-that-makes-one-key-analyst-wonder-about-a-potential-buyout-offer-looming-opdivo-data-and-plan-b/\" target=\"_blank\">three areas that concern investors</a>: the Revlimid patent cliff, a potential switch to smaller buyouts and the elimination of any bids for BMY.</li><li>Analysts say that BMY told them that no deals are \"on the table\" for a suitor to acquire it, leading Mr. Anderson to speculate that possibly an informal offer has been floated.</li><li>Some observers believe BMY wants to acquire CELG to prevent itself from being acquired, especially considering that sales growth for top seller Opdivo may moderate in 2020 and beyond.</li><li>Another aspect of the situation that has everyone's attention is the apparent lack of a \"Plan B\" for BMY if the CELG deal falls through. Mr. Anderson believes that it will have to switch from early-stage to late-stage buyouts to boost growth if this happens.</li><li>Shareholders will vote on the deal next month.</li><li>CELG is up <font color=\"green\">1%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441439\" data-linked=\"Bristol-Myers not quite there in convincing shareholders on merits of Celgene deal\" data-tweet=\"$BMY $CELG - Bristol-Myers not quite there in convincing shareholders on merits of Celgene deal https://seekingalpha.com/news/3441439-bristol-myers-not-quite-in-convincing-shareholders-on-merits-of-celgene-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3441439-bristol-myers-not-quite-in-convincing-shareholders-on-merits-of-celgene-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441437\" data-ts=\"1552308926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFN\" target=\"_blank\">INFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441437-mkm-gives-infinera-another-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MKM gives Infinera another upgrade</a></h4><ul><li>MKM Partners upgrades Infinera (NASDAQ:<a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a>) from Neutral to Buy with a $6 price target, implying a 32% upside.</li><li>Last month, MKM <a href=\"https://seekingalpha.com/news/3436549-infinera-plus-6_5-percent-mkm-upgrades-earnings\" target=\"_blank\">upgraded </a>Infinera to Neutral after an earnings report that included weaker guidance that analysts saw as cable customer timing issues that would pan out.</li><li>Infinera shares are <font color=\"green\">up 6.8%</font> pre-market to $4.85.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441437\" data-linked=\"MKM gives Infinera another upgrade\" data-tweet=\"$INFN - MKM gives Infinera another upgrade https://seekingalpha.com/news/3441437-mkm-gives-infinera-another-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3441437-mkm-gives-infinera-another-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441429\" data-ts=\"1552308153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPD\" target=\"_blank\">RPD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441429-rapid7-plus-2-on-nomura-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rapid7 +2% on Nomura upgrade</a></h4><ul><li>Macquarie upgrades Rapid7 (NASDAQ:<a href='https://seekingalpha.com/symbol/RPD' title='Rapid7, Inc.'>RPD</a>) from Neutral to Outperform citing increased demand for vulnerability management and work flow automation.</li><li>Rapid7 shares are <font color=\"green\">up 2.2%</font> pre-market to $46.05.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441429\" data-linked=\"Rapid7 +2% on Nomura upgrade\" data-tweet=\"$RPD - Rapid7 +2% on Nomura upgrade https://seekingalpha.com/news/3441429-rapid7-plus-2-on-nomura-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3441429-rapid7-plus-2-on-nomura-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441425\" data-ts=\"1552307830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBLU\" target=\"_blank\">JBLU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441425-jetblue-slips-after-barclays-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JetBlue slips after Barclays warning</a></h4><ul> <li>JetBlue (NASDAQ:<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a>) is<font color=\"red\"> down 1.74%</font> in premarket trading to $15.80 after Barclays warns on lack of a traction at the airline in hitting its high-flying expectations into 2020.</li> <li>\"Commercial initiatives can be subject to competitive pressure,\" warns the Barclays analyst team.</li> <li>More from Barclays: \"Despite meaningful capacity expansion and a structural cost program announced over two years ago, JetBlue\u2019s cost performance has yet to meaningfully improve.\"</li><li>Barclays slides JBLUE to an Equal-weight rating after having it slotted at Overweight.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441425\" data-linked=\"JetBlue slips after Barclays warning\" data-tweet=\"$JBLU - JetBlue slips after Barclays warning https://seekingalpha.com/news/3441425-jetblue-slips-after-barclays-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3441425-jetblue-slips-after-barclays-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441424\" data-ts=\"1552307793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDR\" target=\"_blank\">CLDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441424-clouderaplus-2_7-on-equal-weight-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloudera +2.7% on Equal-Weight start</a></h4><ul><li>Barclays initiates Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) with an Equal-Weight rating and $16 target, implying a 16% upside.</li><li>Cloudera will <a href=\"https://seekingalpha.com/symbol/CLDR/earnings\" target=\"_blank\">report earnings</a> on Wednesday. Analysts expect revenue of $208.86M with EPS at -$0.07.</li><li>Cloudera shares are <font color=\"green\">up 2.7%</font> pre-market to $14.20.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441424\" data-linked=\"Cloudera +2.7% on Equal-Weight start\" data-tweet=\"$CLDR - Cloudera +2.7% on Equal-Weight start https://seekingalpha.com/news/3441424-clouderaplus-2_7-on-equal-weight-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3441424-clouderaplus-2_7-on-equal-weight-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441420\" data-ts=\"1552307406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441420-oracleminus-1_9-on-double-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle -1.9% on double downgrade</a></h4><ul><li>Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>) gets a double downgrade as Nomura moves from Buy to Reduce citing unsustainable buybacks.</li><li>The target drops from $53 to $42, implying a 20% downside.</li><li>Oracle shares are <font color=\"red\">down 1.9%</font> pre-market to $51.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441420\" data-linked=\"Oracle -1.9% on double downgrade\" data-tweet=\"$ORCL - Oracle -1.9% on double downgrade https://seekingalpha.com/news/3441420-oracleminus-1_9-on-double-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3441420-oracleminus-1_9-on-double-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441417\" data-ts=\"1552307229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441417-barrick-withdraws-newmont-bid-will-form-nevada-jv-instead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barrick withdraws Newmont bid, will form Nevada JV instead</a></h4><ul><li>Barrick Gold (NYSE:<a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a>) and Newmont Mining (NYSE:<a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation'>NEM</a>) say they will <a href=\"https://seekingalpha.com/pr/17439338-barrick-newmont-forge-nevada-joint-venture-agreement\" target=\"_blank\">create a joint venture</a> combining their respective mining operations and assets in Nevada, ending Barrick's hostile bid to buy its mining rival.</li><li>Barrick will act as the main operator of the assets and own 61.5% of the JV and control three of the five board seats governing it; Newmont will own 38.5% of the JV after earlier proposing a 55-45 split.</li><li>The companies say the JV will allow them to capture an estimated $500M in average annual pre-tax synergies in the first five full years of the combination, which is projected to total $5B pre-tax net present value over 20 years.</li><li>Goldcorp (NYSE:<a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a>), which is scheduled to merge with Newmont, says it <a href=\"https://seekingalpha.com/pr/17439451-goldcorp-announces-support-barrick-newmont-nevada-joint-venture\" target=\"_blank\">welcomes the JV</a> as well as the announcement that Barrick will pull its proposal to acquire Newmont.</li><li>GOLD <font color=\"green\">+2.4%</font>, NEM <font color=\"red\">-0.4%</font>, GOLD <font color=\"green\">+1.8%</font> pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441417\" data-linked=\"Barrick withdraws Newmont bid, will form Nevada JV instead\" data-tweet=\"$GOLD $NEM $GG - Barrick withdraws Newmont bid, will form Nevada JV instead https://seekingalpha.com/news/3441417-barrick-withdraws-newmont-bid-will-form-nevada-jv-instead?source=tweet\" data-url=\"https://seekingalpha.com/news/3441417-barrick-withdraws-newmont-bid-will-form-nevada-jv-instead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441416\" data-ts=\"1552307125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZUMZ\" target=\"_blank\">ZUMZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441416-zumiezminus-2_5-after-pivotal-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zumiez -2.5% after Pivotal cut</a></h4><ul> <li>Zumiez (NASDAQ:<a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a>) tracks lower after Pivotal Research sees an end to the retailer's recent rally.</li> <li>The Pivotal analyst team drops Zumiez to a Hold rating from Buy following the 90-day rally in share price of over 33%.</li> <li>Shares of Zumiez are <font color=\"red\">down 2.48%</font> in premarket action in reaction to the ratings cut.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441416\" data-linked=\"Zumiez -2.5% after Pivotal cut\" data-tweet=\"$ZUMZ - Zumiez -2.5% after Pivotal cut https://seekingalpha.com/news/3441416-zumiezminus-2_5-after-pivotal-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3441416-zumiezminus-2_5-after-pivotal-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441414\" data-ts=\"1552306678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LUV\" target=\"_blank\">LUV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441414-southwest-airlines-lower-amid-safety-scrutiny\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southwest Airlines lower amid safety scrutiny</a></h4><ul> <li>Southwest Airlines (NYSE:<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a>) is <font color=\"red\">down 2.47%</font> after the spotlight in the industry turns to safety following the fatal Boeing 737 Max 8 crash.</li> <li>Southwest operates 31 Boeing 737 Max 8s. The company told Reuters that it's in contact with Boeing about the probe on the 737 Max 8s.</li> <li>Separately, Southwest was warned by the FAA yesterday on the safety risk of an extended contract standoff with its mechanics union.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441330-boeing-minus-9-percent-china-suspends-737-max-8-operations\" target=\"_blank\">Boeing -9% as China suspends 737 MAX 8 operations</a> (March 11)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441383-ground-737-max-8s-black-box-found\" target=\"_blank\">More ground 737 MAX 8s; Black box found</a> (March 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441414\" data-linked=\"Southwest Airlines lower amid safety scrutiny\" data-tweet=\"$LUV - Southwest Airlines lower amid safety scrutiny https://seekingalpha.com/news/3441414-southwest-airlines-lower-amid-safety-scrutiny?source=tweet\" data-url=\"https://seekingalpha.com/news/3441414-southwest-airlines-lower-amid-safety-scrutiny\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441408\" data-ts=\"1552306018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UCTT\" target=\"_blank\">UCTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441408-ultra-cleanplus-3-on-buy-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultra Clean +3% on Buy upgrade</a></h4><ul><li>Craig-Hallum upgrades Ultra Clean Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/UCTT' title='Ultra Clean Holdings, Inc.'>UCTT</a>) from Hold to Buy with a $13 price target, implying a 13% upside.</li><li>Last month, Ultra Clean <a href=\"https://seekingalpha.com/news/3435983-ultra-clean-reports-mixed-q4-outlook\" target=\"_blank\">reported</a> a mixed Q4 with an in-line revenue outlook for Q1.</li><li>UCTT shares are <font color=\"green\">up 3.2%</font> pre-market to $9.95.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441408\" data-linked=\"Ultra Clean +3% on Buy upgrade\" data-tweet=\"$UCTT - Ultra Clean +3% on Buy upgrade https://seekingalpha.com/news/3441408-ultra-cleanplus-3-on-buy-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3441408-ultra-cleanplus-3-on-buy-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441397\" data-ts=\"1552305256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441397-citi-sees-lack-of-catalysts-for-ge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi sees lack of catalysts for GE</a></h4><ul><li>Citi analyst Andrew Kaplowitz has <a href=\"https://www.streetinsider.com/Analyst+EPS+Change/General+Electric+%28GE%29+Citi+Cuts+GE+PT+To+%2414+On+Lack+Of+Catalysts/15239852.html\" target=\"_blank\">cut</a> his price target for General Electric (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric Company'>GE</a>) to $14 from $15 while maintaining a Buy rating on the stock.</li><li>His sum-of-the-parts reflects \"good upside potential for the shares,\" but he adds that \"absent improving cash within a reasonable time horizon, value realization could be delayed.\"</li><li>Kaplowitz still believes GE's recent actions buy the company some time to execute a turnaround.</li><li>GE <font color=\"red\">-0.8%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3441397\" data-linked=\"Citi sees lack of catalysts for GE\" data-tweet=\"$GE - Citi sees lack of catalysts for GE https://seekingalpha.com/news/3441397-citi-sees-lack-of-catalysts-for-ge?source=tweet\" data-url=\"https://seekingalpha.com/news/3441397-citi-sees-lack-of-catalysts-for-ge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441396\" data-ts=\"1552305220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTNX\" target=\"_blank\">NTNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441396-jefferies-ups-nutanix-on-improved-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies ups Nutanix on improved valuation</a></h4><ul><li>Jefferies upgrades Nutanix (NASDAQ:<a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix, Inc.'>NTNX</a>) from Hold to Buy on an improved risk-reward balance after the over 30% pullback following last month's earnings report.</li><li>Analyst John DiFucci highlights the company's \"extremely sticky\" core products.</li><li>The analyst notes that some risks including macro competition remain but expects NTNX to continue expanding its footprint with existing customers while growing into new products.</li><li>Nutanix shares are <font color=\"green\">up 2%</font> pre-market to $35.22.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441396\" data-linked=\"Jefferies ups Nutanix on improved valuation\" data-tweet=\"$NTNX - Jefferies ups Nutanix on improved valuation https://seekingalpha.com/news/3441396-jefferies-ups-nutanix-on-improved-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3441396-jefferies-ups-nutanix-on-improved-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}